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1 Introduction 
Citizens, policy makers and social scientists often call for citizen participation for reasons of 
democratic legitimacy and effectiveness. An important field in which this has been claimed 
vigorously is science and technology policy. Thus, many countries witnessed the introduction 
of Participatory Technology Assessment (PTA). The "litmus test" of PTA, and of citizen 
participation, is their impact on policy-making. 
 But can PTA keep its promises and increase the influence of citizens' voices on 
decision-making? 
 What in actual fact is the impact of PTA on decision-making? 
 How can we increase it? 
In order to answer these questions the project "Impact of Citizen Participation on Decision 
Making in a Knowledge Intensive Policy Field" (CIT-PART) studies comparatively the impact 
of PTA and TA on policy-making in Austria, Canada, Denmark, Italy, Latvia, The 
Netherlands, Sweden, Switzerland, United Kingdom, the European Commission, the OECD 
and the Holy See. From that the project draws conclusions about the potential impact of 
institutionalised citizen participation on EU level. 
This project exemplifies its questions through the reactions of various political systems to the 
challenge of Xenotransplantation (XTP), which stands for the transplantation of animal 
organs, tissues or cells into humans. XTP is highly controversial: Its advocates perceive it as 
promising since it could help to remedy the shortage of human transplants. Its opponents 
insist that it involves too many risks - most prominently infection risks - and ethical questions. 
Adopting a theoretical approach of ―social practices‖ it is assumed in the project that the 
impact of citizen participation on decision-making is not only dependent on the quality of the 
PTA process itself but on practices of policy makers in which PTA is embedded in. Following 
from our theoretical approach the project applies qualitative methods of empirical research. 
The CIT-PART research team involves researchers from anthropology, communication 
studies, political science, public law, social psychology and sociology. 
1.1 Case selection 
Switzerland is an interesting case for the CIT-PART project for several reasons. Firstly, one 
of the companies that invested most heavily in xenotransplantation in the 1990s was the 
Swiss based firm Novartis (then Sandoz), which in April 1996 acquired the UK firm Imutran. 
The close association of the leading industrial investor in xenotransplantation with 
  
Switzerland‘s research and business location was one reason why this technology became a 
matter of debate in the Swiss political system and the general public. After a heated 
parliamentary debate in 1999 on whether to ban xenotransplantation in general, only 
allowing for a few well defined exceptions (as proposed by the Swiss government, the 
Federal Council, Bundesrat), the majority of the Swiss Parliament finally decided for an in 
principle permissive policy approach. In two subsequent laws, which came into effect in 2001 
and 2004, the Parliament stipulated strict requirements for research and rules of liability prior 
to authorization of clinical trials (Eidgenössisches Department des Innern 2001). 
Secondly, Switzerland is interesting because there was some xenotransplantation research 
taking place. Novartis and several research groups at university hospitals were active in this 
field. Research at university hospitals, however, did not focus on solid organ, but on cellular 
xenotransplantation (Bellucci et al. 1998: 157). 
Thirdly, and most importantly, in the late 1990s the parliamentary Swiss Technology 
Assessment Programme (later renamed TA-Swiss) commissioned two TA studies on solid 
organ as well as cellular xenotransplantation (Hüsing et al. 1998 and 2001) and in 2000 a 
participative technology assessment exercise (PTA), called PubliForum 
Transplantationsmedizin (ZTA 2001).
1
 In the PubliForum 28 citizens discussed problems of 
transplantation policy in general and in one working group specifically focused on the 
problems of xenotransplantation. Thus, Switzerland, besides Canada and the Netherlands, is 
one of the few countries in which PTA on xenotransplantation was carried out. 
Finally, Switzerland is also interesting for our sample due to its political system. Its strong 
elements of direct democracy provide an opportunity to investigate the institutional match 
between PTA and direct democracy. 
1.2 Methods 
For this case study I interviewed eleven experts from TA-organizations (3 TA-Swiss, 1 
Fraunhofer Institute for Systems and Innovation Research (FhG-ISI)), xenotransplantation 
research (3), public administration (2), politics and bioethics (1 interviewee each; see list of 
interviews). The interview partners were either involved in xenotransplantation research, TA 
and PTA on xenotransplantation and/or the respective policy making process. 
The interviews were carried out from May to September 2010 in Switzerland and Austria. 
They were taped, fully transcribed and analysed using ATLAS.ti, a software package for 
qualitative content analysis. Data analysis followed Meusser and Nagel‘s (2002) suggestions 
                                                     
1
 The names used by TA Swiss on its publications changed over the years. Names used are Schweizerischer 
Wissenschafts- und Technologierat, TA Programm Schweiz, Technikfolgenabschätzung, Technology Assessment, 
Zentrum für Technikfolgen-Abschätzung. In this paper I indicate the name which was used in the respective 
document. 
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for analyzing expert interviews and focussed entirely on the manifest content. In the text 
interviews are for the most part paraphrased, sometimes they are also quoted verbatim. In 
both cases the number of the interview (see Annex) and the line numbers of the transcripts 
are indicated in the text. 
Besides these interviews the case study includes an analysis of material from the Fraunhofer 
Institute for Systems and Innovation Research (FhG-ISI), generated during their TA studies 
on xenotransplantation in the late 1990s, which I collected at a research stay in Karlsruhe in 
November 2010. Moreover analysis covers documents and publications provided by TA-
Swiss on the TA and PTA on xenotransplantation, materials produced during the lawmaking 
process (e.g., draft bills, reports, records) and newspaper articles provided either by 
interview partners or retrieved from the Internet. While the interviews provided the backbone 
for this case study the documents were used as additional factual information on the policy 
process and public discussion of xenotransplantation in Switzerland as well as a means to 
corroborate and check information gained in the interviews. The latter was crucial because 
more than 10 years passed since the regulation of xenotransplantation and since the TA and 
PTA on this topic. The documents therefore provide material which is not affected by the 
later reinterpretation of interviewees. 
All translations of interviews and documents are by the author. 
1.3 Acknowledgements 
I want to express my deep gratitude to all interview partners from various Swiss 
organizations for their unhesitating and welcoming readiness to participate in the project. 
Without their friendly and open support this research would have been impossible. I 
particularly want to thank Dr. Bärbel Hüsing who patiently answered my numerous questions 
and generously provided her time, knowledge and archive material. I also want to thank 
Claudia Jandrisic and Karina Weitzer for transcribing the interviews. 
1.4 Layout of the paper 
In the interviews several basic narratives can be distinguished which are connected to 
different institutions, i.e. the narrative of TA-researchers, civil servants, politicians and 
xenotransplantation researchers. I will analyze the history of TA and PTA on 
xenotransplantation in Switzerland mainly by following these narratives. I will try to work out 
how these different streams of narration met in TA and PTA and find out their different 
experiences thereof. By following these narratives I will answer the main research questions 
of the CIT-PART project. The paper starts with a table providing an overview on the 
development of xenotransplantation policy in Switzerland. Thereafter I turn to the question 
whether xenotransplantation was an issue of public debate, a controversy, what the positions 
therein were? The next section turns to the actual xenotransplantation policy and sketches 
  
two regulatory fields, in which this technology was regulated, i.e. the Federal Decree on the 
Control of Blood, Blood Products and Transplants of 1996 (amended 1999) and the 
transplantation law of 2004. This is followed by an analysis of the main actors (research, 
industry, critical NGOs, Parliament, Federal Office of Public Health, TA Swiss), positions and 
activities. I will then turn to TA and PTA activities in the context of xenotransplantation and its 
impact. The next chapter deals with political practices and PTA. In the final section I will 
summarize my findings and draw main conclusions. 
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Table 1: Overview of landmark developments and timeline 
 1993 1994 1996 1997 1998 1999 2000 2001 2004 2007 
   consultation governmental 
bill 
governmental 
Bill for interim 
regulation 
 Organizes 
and 
participates 
in 
PubliForum 
implements 
authorization 
as passed by 
Parliament 
  
Parliament: 
Amendment 
of the 
Federal 
Decree on 
the Control of 
Blood, Blood 
Products and 
Transplants 
  Initiative for 
moratorium 
Government 
declines 
moratorium 
Commission 
declines 
moratorium 
and asks for 
a regulation 
that requires 
authorization 
of clinical 
trials 
Government. 
Bill for interim 
regulation 
National 
Council 
accepts bill 
Council of 
States 
declines ban 
Council of 
States 
accepts 
Council of 
States‘ 
proposal 
    
Parliament: 
Trans-
plantation 
(TP) law 
Motion 
demands a 
ban on trade 
with human 
organs 
Motion 
demands 
constitutional 
and legal 
basis to 
regulate TP 
Parliament 
decides on 
consultation 
for a federal 
regulation of 
TP 
Report on 
consultation 
 Referendum 
passes with 
more than 
88% 
 Government. 
bill on TP 
Federal law 
on the TP of 
organs, 
tissues and 
cells passed 
TP law in 
effect 
TA-Swiss   Open call for 
tender for TA. 
Deadline: 
7.11. 
TA study 
finished 
Press release 
and public 
presentation 
Steering 
Committee 
discusses 
impact of TA. 
OECD 
conference 
PubliForum 
TA cellular 
XTP 
Press release 
Lunch for 
MPs 
   
XTP-
Research 
    TA (advisory 
group) 
Research 
conference 
OECD 
conference 
Statement of 
Academy of 
Medical 
Sciences 
PubliForum 
(expert) 
   
Basel Appeal   Public 
campaign 
 TA (advisory 
group) 
 PubliForum 
(expert) 
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2 The Swiss Xenotransplantation Debate 
2.1 Public debate 
This section addresses the question of whether there was a public discussion on 
xenotransplantation in Switzerland at all; if so, whether this can be described as 
controversial and what the basic positions taken by different actors were. 
Xenotransplantation definitely became an issue of public debate in Switzerland in the 1990s 
in Parliament, parliamentary commissions and the media (Interview 1: 30-38), although the 
debate was neither extensive nor continuous. Several parliamentary institutions and 
activities dealt with the question of whether a moratorium or even a ban on 
xenotransplantation would be an appropriate policy measure (see below). Newspapers also 
repeatedly contained reports concerning the issue of xenotransplantation. According to a TA-
researcher, stories on xenotransplantation were covered by the mass media following 
reports of scientific breakthroughs with an undercurrent of discomfort, futurism and horror 
(Interview 5: 116-120; 251-260). An interviewed scientist shared this view and recalled a 
small, discontinuous and marginal debate, which reached its peak two or three times when 
circling around scientific breakthroughs and political developments such as the parliamentary 
debate. However, eventually public interest faded when xenotransplantation research did not 
advance as rapidly as predicted (Interview 6: 098-106). An interviewed politician also 
assessed public as well as parliamentary debates on xenotransplantation as marginal 
(Interview 3: 138; 220-221). Bringing xenotransplantation on the parliamentary agenda, 
however, contributed to turning the topic into an issue of some public attention. In her view, 
on the political level xenotransplantation was linked to discussions about gene therapy, stem 
cell research and other spectacular biomedical processes because there was a general lack 
of regulation of these issues at that point (Interview 3: 12-18). Thus, in summary, public 
debate on xenotransplantation can be described as small and of concern to only a small 
group of informed actors. 
The Swiss xenotransplantation debate was also controversial and the positions taken therein 
ranged ―from clear approval to strict rejection‖ (Bellucci et al. 1998: 157). According to an 
interviewed scientist who summarized the opposing views, there were people interested in 
this new and innovative development while others were in principle opposed. In his opinion, 
they considered xenotransplantation as condemnable and dangerous, without providing the 
respective data, because of their fear of the new and unpredictable (Interview 8: 130-142). 
Several interview partners pointed out a kind of xenotransplantation hype in the 1990s, 
which was characterized by exaggerated forecasts, promises and hopes triggered by a 
market study which forecasted a huge increase of xenotransplantation in the coming years. 
(Laing 1996). During this hype, which eventually faded, supporters argued that 
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xenotransplantation could alleviate organ shortage, contribute to saving patients‘ lives and 
increase their quality of life.
1
 The advocates‘ main argument was to help patients and, from 
the perspective of an interviewed scientist, there are in principle no immunological and 
physiological arguments today, which could absolutely obstruct this technology (Interview 8: 
119-125). In this line of argument xenotransplantation was framed by organ shortage and its 
alleviation (Interview 1: 45-47; 57-58; Interview 4: 58-61). Advocates responded to the 
argument that xenotransplantation would exploit animals by emphasizing the fact that 
millions of pigs would be slaughtered each year for food in Switzerland anyway (Interview 8: 
273-287) and that using animals for a cure would be a far higher goal than eating them 
(Interview 4: 71-81). 
In contrast to this assessment an interviewed TA-researcher recalled that actors opposing 
xenotransplantation argued along various lines. They came from a tradition critical of 
biotechnology and also brought new aspects into the debate. In her opinion, their arguments 
are not to be considered as naïve and emotional, in the sense of being primarily based on 
pitying suffering animals. Rather, challengers of xenotransplantation raised concerns over 
the keeping and raising conditions of source animals (Interview 2: 116-137). They introduced 
aspects of animal welfare into the debate and raised concerns about potential infection risks, 
which were brought up by virologists. The opponents questioned patients‘ survival rates, the 
quality of life of recipients and raised possible problems of identity as well as of 
psychological states (Interview 2: 155-164). 
The biotechnology critical NGO ―Basler Appell gegen Gentechnologie‖
2
 repeatedly argued 
that advocates of xenotransplantation would consider this approach a medical quantum 
jump
3
 while, in their view, it would basically just result in spectacular profits for the 
pharmaceutical industry. From their perspective, xenotransplantation would involve a threat 
for entire mankind because pathogens and viruses might cross the animal/human barrier. 
Moreover, they questioned whether it would be ethically acceptable to genetically modify 
animals. 
Questions of animal welfare, however, were not central in the arguments of a critical 
politician who was very active in bringing xenotransplantation on the political agenda. She 
emphasized the importance of regarding the choice of research areas as power politics and 
described transplantation medicine as an ideology of organ storage and replacement 
                                                     
1
 Today the interviewed TA researchers and civil servants considered xenotransplantation as rather unlikely to be 
realized, particularly in the case of solid organs. Also xenotransplantation researchers criticized the hype of the 
1990s in the interviews. However, they were more optimistic about the general prospects of xenotransplantation. 
They emphasized the slow and incremental progress of research which might eventually lead to cellular as well as 
even solid xenotransplantation. Moreover, in their opinion, xenotransplantation research would also benefit 
allotransplantation. 
2
 I will use in the following a rough English translation of their name, i.e. Basel Appeal against Genetic Engineering, 
or short Basel Appeal. 
3
 This phrase turns up frequently, e.g. in a brochure of Basel Appeal to press reports and Parliamentary speeches 
(NZZ 1999a: 16). 
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(Interview 3: 90-108). Moreover, she criticized the fact that in health debates individual 
human life would be considered of paramount importance while the question of ethical limits 
to medical procedures, e.g., because of unpredictable risks, consequences for public health 
and the transgression of an animal/human barrier, would not be raised (Interview 3: 248-
312). 
According to a qualitative survey on the various positions which different Swiss organizations 
took on xenotransplantation Hüsing at al. (1998: 172 ff.) came to the conclusion that 
advocates promoted xenotransplantation because of its promises to alleviate human 
suffering and because this technology was regarded as the logical consequence of 
allotransplantation. The use of animals would also be justified, in this perspective, if 
unnecessary harm to animals could be avoided. In principal the keeping and breeding of 
animals for human use would not be a new practice. However, xenotransplantation would be 
subject to the fulfillment of certain requirements such as research to minimize risk of 
infection; solutions to hyper acute and later rejection mechanisms; guarantees of human 
dignity, identity and health; guarantees of animal welfare; definition of an organizational, 
legal, ethical and societal framework of conditions under which xenotransplantation can be 
carried out. 
Critics of xenotransplantation in contrast reasoned with a plethora of wide ranging 
arguments: 
 New pathogens might be created by transgressing the species boundary. 
 The problem of hyper acute rejection and subsequent rejection mechanisms might 
not be resolvable or only with a high use of resources. Alternatives, on the other 
hand, may be realized faster, more cost effectively and might be more socially and 
ethically acceptable. 
 This approach of spare part medicine might cause long-term changes in the 
relationship of humans to their own body, the relationship between animals and 
humans, as well as towards sickness and death. 
 The creation of chimeras through xenotransplantation might result in changes of 
identity in recipients. 
 Xenotransplantation might only be achieved by means of unacceptable experiments 
on humans. 
 The breeding and keeping of animals for xenotransplantation would require species-
inappropriate conditions. 
 Xenotransplantation would increase the use of animals quantitatively. 
 The approach would involve the cloning of animals, which has to be rejected. 
 The production of animals through genetic modification would not be in accordance 
with the constitutional ―dignity of creatures‖. 
 Xenotransplantation does not fit with a human and fair health care system. 
 Xenotransplantation would act against efforts to strengthen prevention. 
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 It would increase costs for the health care system and decrease the readiness for 
organ donation. 
 As long as there is no basic health care in developing countries xenotransplantation 
as expensive top medicine has to be refused for reasons of global inequality. 
 Society would not accept xenotransplantation and there would be less controversial 
alternatives. 
 Society should discuss the issue before definite decisions are made; big enterprises, 
particularly Novartis, would create a monopoly and gain profits without competition. 
 Finally, financial interests might suppress a democratic public debate (Hüsing et al. 
1998: 174 ff.). 
These conflicting standpoints became obvious during the year 1999 when in both chambers 
of the Swiss Parliament the option of a temporary ban was controversially discussed (see 
below). 
Virologists were positioned somewhere in between these two camps. Although the 
(according to an interviewed TA-researcher‘s analysis) ―euphoric‖ (Interview 2: 130) 
transplantation surgeons considered virologists as peers because these were also scientists, 
they also regarded them as ―spoilsports‖ because of their raising questions regarding risks, 
which again were picked up by critical NGOs (Interview 2: 116-137). A xenotransplantation 
researcher considered the discovery of a potential risk of infection as a catastrophe, which 
almost killed the research area entirely. Today, however, he assessed the risk of infection as 
less serious than it was considered in the late 1990s (Interview 8: 86-117). 
In Parliament, xenotransplantation was primarily discussed in the context of research and 
economic policy. In repeated debates in the National Council and the Council of States in 
1999, members of Parliament from conservative and liberal parties emphasized the 
importance of the pharmaceutical industry and its interest in xenotransplantation research for 
Swiss research and Switzerland as a business location. They opposed a ban or moratorium 
because they argued that Switzerland could not stand alone with such a political measure. 
Pointing out the promises of xenotransplantation, they advocated research into 
xenotransplantation with prior authorization (see below). 
The responsible ministry, the Federal Office for Public Health (FOPH, Bundesamt für 
Gesundheit) also identified xenotransplantation as a hot issue in 2001 by stating that 
―xenotransplantation is being controversially debated in the public for technical, political, 
ethical and emotional reasons‖. Drawing from the consultation procedure on their proposed 
transplantation law, which included a regulation of xenotransplantation and which most 
respondents criticized or rejected, the FOPH provided several arguments why 
xenotransplantation was refused by Swiss civil society, i.e. risk of infection, animal welfare, 
uncertain medical and economic benefits and ethical concerns (Eidgenössisches 
Department des Innern 2001). 
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In contrast to the majority in Parliament the FOPH, took a restrictive and cautious approach 
towards xenotransplantation because of the potential risks of creating new viruses, which 
would be hard to control and could create epidemics. Though they also discussed ethical 
issues, the risk of infection was their main focus of criticism of xenotransplantation (Interview 
4: 318-324) while animal welfare was less of an issue (Interview 4: 367). 
Thus, as one interviewed TA-researcher summarized, the framing of the Swiss 
xenotransplantation debate was not much different from other countries. However, a 
distinguishing dimension of the Swiss case was that actors critical of biotechnology and 
animal welfare activists were well organised and positioned because of their previous 
activities (Interview 2: 116-137). 
2.2 Xenotransplantation regulation 
Before relevant regulation came into effect, provisionally in 2001 and finally in 2007 (see 
below), it was permissible in Switzerland to carry out xenotransplantation without prior 
authorization by authorities. The Federal Decree on the Control of Blood, Blood Products 
and Transplants regulated the protection against infection (Nationalrat 1997a: 3). This 
decreed that tests had to be carried out and that state of the art measures had to be taken to 
exclude zoonoses and diseases from prions, which might cause infections in humans 
(Nationalrat 1996a: 3, Hüsing et al. 1998: 127). No prior authorization but only a notification 
of authorities was required. 
This permissive environment changed in 2001 when the FOPH, following a motion from the 
parliamentary Commission of Science, Education and Culture in 1997 decided to make 
clinical research on xenotransplantation subject to prior authorization (see below). This 
became necessary because the Commission did not want to wait until a transplantation law, 
which would also regulate xenotransplantation and was then being debated, finally came into 
effect. Because of what it assessed as a high risk of infection, the Commission decided that 
speedy action was necessary (Interview 263-269) and asked the government to work out a 
bill stipulating prior obligatory authorization for clinical trials of xenotransplantation (Interview 
2: 272-273). 
The FOPH, who was in charge of the issue within government wanted to take a strict 
approach in its draft bill by creating a high threshold for clinical trials. This was to be 
accomplished by a general ban of xenotransplantation trials with authorized exceptions 
(Interview 4: 287-293). However, this proposed article became the center of controversy in 
both chambers of Parliament between conservative and liberals on the one side and social 
democrats and the green party on the other side and did not pass (see below). Parliament 
decided to reject a moratorium and instead require prior authorization of xenotransplantation 
by the FOPH. Liability regulations for xenotransplantation research were formulated 
according to the Swiss model for genetically modified organisms (Interview 4: 377-383). 
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In Chapter 3, Article 43 the transplantation law of 2004 which adopted the previous 
regulations formulated in the amendment of the Federal Decree on the Control of Blood, 
Blood Products and Transplants stipulates that xenotransplantation of organs, tissues and 
cells is subject to prior authorization by the FOPH (Bundesversammlung der 
Schweizerischen Eidgenossenschaft 2007) and determines under which conditions such an 
authorization has to be issued. Permission for clinical trials has to be granted: 
(a) if the risk of infection for the population can be ruled out with a high probability; 
(b) therapeutic benefit is expected, 
(c) necessary technical and operational requirements are met; 
(d) quality insurance systems are in place. 
Authorization for xenotransplantation as standard procedures is to be granted if the risk of 
infection for the population can be ruled out and therapeutic benefit has been established as 
well as the previously mentioned conditions described by (c) and (d) are met. 
According to Article 44 the holder of a permit has to examine the recipients regularly over a 
long period of time for pathogens or indications thereof, to carry out a post mortem of a 
recipient for infections; document relevant information and incidents; document in a way that 
source animal and recipient as well as biological probes can be traced; to store these 
documents and probes and to provide them to authorities on demand so these can take 
immediate and necessary steps to protect the health of the population and to inform 
authorities if required. 
Moreover, according to Article 45 organs, cells and tissues of animals have to be tested for 
pathogens or indications thereof. 
In order to cover potential liability claims Article 46 stipulates that the holder of a permit can 
be required to take liability insurance. According to Article 47 the liable party has to bear the 
costs for measures that authorities have to take to hold or reduce the risk of infection for the 
population and to determine and repair the damages caused by infection. 
In addition the government will decree a directive on the handling of organs, tissues and 
cells of animal origin regarding the (a) dealing with source animals, (b) the quality of animal 
organs, tissues and cells, (c) requirements for the tests carried out to monitor health of 
recipients and source animals, (d) preconditions for the authorization and authorization 
procedure, (e) duration and kind of storage of documentation and biological probes, (f) 
requirements on which pathogens or indications thereof must be tested; (g) in which cases 
organs, tissues and cells can be transplanted despite reactive test results; (h) identification 
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of organs, tissues and cells, which have been harvested from genetically modified animals 
as well as (i) requirements for (1.) informed consent, (2.) information and approval of medical 
personnel, (3.) information of contact persons and recipients. 
An interviewed researcher regarded the law as positive in principle but also considered the 
regulation as too restrictive. If clinical trials become promising in the future these (as he 
perceived them) administrative and bureaucratic hurdles might prove prohibitive (Interview 8: 
306-316). 
2.3 Actors 
After having sketched out the Swiss xenotransplantation debate and policy, in the following 
section, I will introduce the most important actors of the debate as well as their involvement 
in the policy development. 
2.3.1 Research 
According to an interviewed scientist there was not much xenotransplantation research in 
Switzerland (Interview 8: 66-84). Several research groups participated in EU funded 
research projects and were trained by and/or collaborated with US researchers (Interview 8, 
Interview 10). There was no research in solid organ but rather in cellular xenotransplantation 
(Schweizerischer Bundesrat 2001: 51). 
In its answer to a parliamentary interpellation in 1996 the government stated that in 
Switzerland no xenotransplantation on humans has been carried out but that animal cells 
were used as vector cells in gene therapy. At four hospitals in Zurich, Lausanne, Bern and 
Geneva animal cells were used for clinical trials. At the university hospitals in Geneva and 
Lausanne animals were kept and raised for research in the area of xenotransplantation. 
Sandoz/Novartis also did research in the area of xenotransplantation and kept and raised 
animals for that purpose. These experiments were restricted to animal-to-animal 
transplantation (Nationalrat 1996a: 1 ff.). 
Researchers played an active part in the xenotransplantation debate. They participated in 
the TA study on xenotransplantation as interviewees as well as members of the advisory 
group (see below). They also contributed to the PubliForum: again, as members of the 
advisory group, as informants of the lay panel in the preparatory weekends and in the public 
event as well (see below). Experts also participated in the public debate by giving interviews 
and writing articles in newspapers (Interview 8: 41-44, e.g., Seebach 2001). 
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2.3.2 Industry 
Industry, namely Novartis, played an important role in the Swiss xenotransplantation debate. 
Several interview partners agreed that one reason why xenotransplantation became topical 
in Switzerland was that Novartis, which was heavily investing in this technology, had its 
headquarters in this country (Interview 1: 005-007, Interview 8: 66-84, Interview 2: 49-57). 
The fact that Novartis was one of the ―global players‖ (Bastian: 1997) and main potential 
profiteers of xenotransplantation was repeatedly reported and discussed in the press (NZZ 
1996: 23, SonntagsZeitung 1996b) as well as criticized by biotechnology critical NGOs (see 
below). Though Novartis did not do much xenotransplantation research in Switzerland itself, 
it owned the UK based firm Imutran and also supported research in the U.S. with money and 
patents (Interview 6: 63-76). 
Several interview partners emphasized Novartis‘ financial interest in xenotransplantation 
(Interview 1: 042-044, 053-056, NZZ 1999b: 16) and the fact that xenotransplantation might 
turn transplantation medicine, which mainly relies on donations and where the main market 
is for immunosuppressive drugs, into a lucrative business. If industry could provide animal 
organs, much money would be involved (Interview 2: 061-068). 
Novartis opposed a Swiss ban or moratorium on xenotransplantation. In an interview carried 
out by members of the press, head researcher Paul Herrling considered the probability of 
infections as rather small. His firm would not be happy with a moratorium as advocated by 
Fritz Bach, a leading US xenotransplantation researcher, because ―a moratorium of 
undefined duration would be of use to nobody because it would block research‖ (Basler 
Zeitung 1998). 
Dietrich W. Scholer, by then head of Novartis pharma policy, could also not follow the TA 
study‘s cautious approach towards xenotransplantation. Novartis would take questions of 
risk rather seriously and more research was needed exactly for that reason. A moratorium, in 
his view, would be counterproductive. He criticized the government for its plan to ban 
xenotransplantation, which, from an international perspective, would be an exception (NZZ 
on/line 1998). 
Repeatedly members of the National Council and Council of States critical of 
xenotransplantation criticized the influence of the pharmaceutical industry on politics in their 
contributions to debates (NZZ 1999a: 16). Paul Herrling, head of research at Novartis, was 
also invited as an expert in a meeting of the parliamentary Commission of Social Security 
and Health on 14.2.1999, which discussed Swiss xenotransplantation policy 
(Parlamentsdienste 1998). Novartis representatives also participated in the advisory group of 
the TA study (see below) and watched its progress with close scrutiny (Interview 2: 363-
370). 
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2.3.3 Critical NGOs 
Though a number of different NGOs gave their opinion in the formal consultation process on 
the transplantation law (Eidgenössisches Department des Innern 1997a), the most 
significant, influential and active NGO in the xenotransplantation debate was Basel Appeal.
4
 
Basel Appeal essentially contributed to the public debate on xenotransplantation in 
Switzerland by putting the issue on the agenda and ‗creating a public‘. The NGO was 
founded in 1988 by a group of people critical of biotechnology who had previously been 
active in the anti-nuclear movement. Having learned their lesson from the conflict about 
nuclear energy, they formed the organization after a conference on reproductive medicine 
and biotechnology with the intention of raising a technological issue early on so as to be 
politically successful (Interview 3: 61-66). Areas of activity were campaigns against ―GMO 
food, patenting of life, deliberate release of a vaccine against rabies from the biotechnology 
lab, enzymes for washing powder from biotechnological production‖ (Basel Appell 1996a: 
44). Though Basel Appeal was active throughout Switzerland, it was based and mainly 
active in Basel (Interview 3: 69). 
The issue of xenotransplantation was brought into the group by one of its board members, 
Florianne Koechlin, a biologist and chemist by training. The NGO started its campaign 
against xenotransplantation in 1996. This involved a number of activities: 
 In 1996 Basel Appeal published an informed and extensive brochure (Basler Appell 
1996a). This booklet of 44 pages, mostly authored by Florianne Koechlin, deals in 
several short articles and in a detailed way with issues relevant to 
xenotransplantation such as the behaviour and keeping conditions of pigs, hyper 
acute rejection, post-transplantation-chimaeras, risk of infection and xenozoonosis, 
problems of genetic modifications of animals, the business of transplantation and 
xenotransplantation (particularly emphasising the role of Novartis) and potential 
consequences of xenotransplantation for the identity of recipients. It also provides an 
overview on possible applications (Basler Appell 1996a). 
 Basel Appeal petitioned for a moratorium until 2020 and collected a total of about 
6,500 signatures (Tages Anzeiger 1996). 
 They contributed to the formal and informal consultation procedure on the 
transplantation law and the Federal Decree on the Control of Blood, Blood Products 
and Transplants respectively. 
 Florianne Koechlin gave a number of interviews to the press (SonntagsZeitung 
1996a, Die Ostschweiz 1997). 
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 www.baslerappell.ch/ (download: 30.12.2010). 
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 She was informant on xenotransplantation in the PubliForum and discussed the 
results of the TA study xenotransplantation on occasion of its public presentation on 
7.9.1998 at a Roundtable (Technology Assessment 1998). 
 Members of the group were in both the advisory group of the TA as well as the 
PubliForum (see below). 
2.3.4 Parliament 
Since one of Basel Appeal‘s board members, Margrith von Felten, was also a member of the 
National Council for the Social Democratic Party (SPS), the NGO had connections to the 
federal legislative. On 5.6.1996 Mrs. von Felten brought xenotransplantation on the 
parliamentary agenda by turning Basel Appeal's call for a moratorium into an interpellation to 
the Federal Council (Nationalrat 1996a) and on the same day, almost verbatim, into a 
parliamentary initiative addressed at the Committee for Science, Education and Culture 
(Nationalrat 1996b). 
2.3.4.1 Interpellation von Felten (96.3223) 
In her Interpellation Mrs. von Felten asked nine questions about xenotransplantation 
research in Switzerland, its risks and ethical problems, the political measures the federal 
government was considering and its readiness to decree a moratorium (Nationalrat 1996a). 
The government replied several months later on 14.8.1996 by writing that the question of 
under what circumstances xenotransplantation should be permitted would be considered 
during the development of a transplantation law (see below). The government did not see at 
this time a cause to take measures in the form of a moratorium in the case of 
xenotransplantation (Nationalrat 1996a: 3). 
2.3.4.2 Parliamentary Initiative von Felten (96.419) 
In her second parliamentary activity, the parliamentary initiative, Mrs. von Felten stated that, 
―because of the completely open ecological, medical, ethical and sociopolitical questions a 
moratorium for experiments with xenotransplantation on humans is urgently necessary; an 
according bill is to be prepared‖ (Nationalrat 1996b: 1). In her explanatory statement she 
quoted Basel Appeal‘s brochure and argued against xenotransplantation, mentioning the 
examples of Ebola, BSA and AIDS because of the risks of infection they pose. She also 
raised ethical questions about genetic modification of animals, using animals as ―organ 
storage‖ for humans and the transgression of the boundary between animals and humans 
(Nationalrat 1996b: 2). 
The Committee for Science, Education and Culture dealt with this initiative almost one year 
later on 22.5.1997 (Nationalrat 1997a). It declined a moratorium with a majority of 15 to 9 
votes. According to its report, the majority and minority agreed that xenotransplantation 
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posed several questions and problems, which would need reflection. However, the majority 
believed that this technology was getting increasingly important, independently of the 
question whether it was responsible from an ethical and health perspective; research was 
therefore not stopped. In practice a moratorium would not mean a pause and time for 
reflection but a complete prohibition and end for research. In the majority‘s opinion, 
Switzerland could not stand apart from international developments and regulations therefore 
had to be made parallel to the development of research (ibid.). In a nutshell, these were 
already the arguments that would be used by opponents of a prohibitive approach to 
xenotransplantation in the coming parliamentary battle over a ban or moratorium. 
In contrast, the minority thought that a moratorium would not entirely stop research but would 
provide time for discussion and reflection, e.g. in a consensus conference. A moratorium 
would not prevent research because risk research with cell cultures could continue. 
2.3.4.3 Motion Commission Science, Education and Culture (97.3251) 
Despite the rejection of a moratorium, the commission‘s majority of 11 votes, with 5 contra 
and 7 abstentions, recognized that there was need for speedy action because of the risk of 
infection. They therefore asked the Federal Council to regulate xenotransplantation 
provisionally by making it subject to prior authorization. The commission asked government 
to prepare this provisional regulation because it regarded the period until xenotransplantation 
would be definitely regulated by a comprehensive transplantation law as too long. The 
minority declined this motion because, in their view, it would in principle permit 
xenotransplantation (Nationalrat 1997b: 3). 
Although both the interpellation and parliamentary initiative were actually declined, they were 
still quite consequential and, by putting the issue on the parliamentary agenda, significant 
steps towards an interim regulation of xenotransplantation in 2001.
5
 
2.3.4.4 Amendment of the Federal Decree on the Control of Blood, Blood Products 
and Transplants (98.035) 
On 13.8.1997 the government declared its readiness to accept the parliamentary motion and 
pointed out the fact that an amendment of the Federal Decree on the Control of Blood, Blood 
Products and Transplants (SR 818.111) from 22.3.1996 would be necessary to make 
xenotransplantation subject to prior authorization. This law, not mentioning it explicitly, 
already allowed xenotransplantation implicitly and in principle; however in article 18 only 
stipulated a reporting obligation and in Article 19 specified a testing obligation to ensure 
protection from infection (Bundesrat 1998: 10 ff.). 
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 Also the Parliamentary Commission on Social Security and Health passed a motion on 7.11.1997 asking for a 
moratorium for xenotransplantation. 
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On 3.6.1998 the governmental bill was sent to Parliament and, in contrast to the position 
taken by government in the reply to the Interpellation von Felten, in principle proposed a 
temporary ban of xenotransplantation of organs tissues and cells of animal origin into 
humans (Art. 18a Abs 1) and only allow for two exceptions. 
 Firstly, xenotransplantation of cells, tissues and organs might be allowed if they are 
carried out within clinical trials and are authorized by the FOPH. 
 Secondly, xenotransplantation of certain cells and tissues of animal origin might be 
allowed if the risk of infection for the population can be excluded according to the 
state of the art. Moreover, authorization depends on a therapeutic benefit of the 
intervention having been proven (Bundesrat 1998: 3; 27 ff.). 
 
This theoretical ban on xenotransplantation was proposed as a temporary solution, for about 
three years, until a comprehensive federal transplantation law would definitely regulate the 
issue of xenotransplantation. It was anticipated that the latter would be implemented by 2002 
at the earliest (Bundesrat 1998: 3, NZZ 1998). 
The Ministry did not carry out a full-fledged formal consultation for this draft bill but, since the 
amendment was only temporary and its content already laid down by the National Council, 
only an informal one.
6
 Animal welfare organizations, NGOs critical of biotechnology and the 
Swiss Science Council welcomed the ban. Representatives of industry, medicine and 
science, on the other hand generally welcomed the obligation for authorization but were 
either rigorously against or more hesitant regarding a temporary ban. Particularly the Swiss 
Association for the Chemical Industry declined a temporary ban and pointed out that such a 
regulation would be disproportionate and unjustified, since concrete indications would be 
missing that xenotransplantation either caused concrete dangers and damages already or 
that these might be impending according to recent scientific findings (Bundesrat 1998: 18ff.). 
The results of the already mentioned discussion in the Commission for Science, Education 
and Culture and the rather oppositional statements in the informal consultation leads one to 
suspect that the governmental bill had a history of controversy in the two chambers. Actually 
it was finally not adopted as proposed by the government. The question of a temporary ban 
or, in other words, whether Switzerland should take a restrictive position and say ―no‖ to 
xenotransplantation ―unless‖ certain requirements were met, as proposed by the 
government, or whether to take a permissive ―yes, but‖-position and to allow 
xenotransplantation in principle with strict requirements, lay at the center of the controversy. 
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 Organisations invited were: Gesellschaft für Chemische Industrie, Interpharma, Swisstransplant, der 
Schweizerische Wissenschaftsrat, das Institut de droit de la santé de l‘Univeristé de Neuchatel, der Basler Appell 
gegen Gentechnologie, die Schweizerische Arbeitsgruppe Gentechnologie, die Schweizerische Akademie der 
Medizinischen Wissenschaften, die Verbindung der Schweizer Ärzte, der Schweizer Tierschutz und der 
Schweizerische Nationalfonds zur Förderung der wissenschaftlichen Forschung. 
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In the first debate on the bill on 4.3.1999 that took place in the National Council, the first and 
bigger chamber of Swiss legislative, this conflict was already played out (Amtliches Bulletin 
1999a, NZZ 1999a, 1999b).
7
 
Neither the restrictive faction, consisting of the Green Party and Social Democratic Party 
(SPS), who wanted a total ban without exception (see e.g. Berner Tagwacht 1997, Tages-
Anzeiger 1997), nor the permissive faction of Christian Democratic People‘s Party (CVP), 
Free Democratic Party (FDP) and Swiss People‘s Party (SVP), who did not want to take a 
prohibitive approach but only wanted to stipulate strict requirements, could yield a majority. 
Finally, the National Council adopted the governmental draft with 88 to 79 votes (Vanoni 
1999). 
Because of the majority‘s concerns about transplantation patients and the Swiss research 
location, the Council of States, the smaller second chamber, decided on 10.6.1999 against 
the governmental draft of a ban with 26 to 7 votes. It voted for permitting xenotransplantation 
of organs, cells and tissues after prior authorization and under certain requirements 
(Amtliches Bulletin 1999b, Vanoni 1999). 
In order to settle the difference between the two equal chambers the plenum of the National 
Council, out of concern for the research location, followed the very close vote of its 
commission and permitted xenotransplantation of organs, cells and tissues with certain 
requirements on 8.10.1999 (Amtliches Bulletin 1999c, Vanoni 1999).
8
 This temporary 
regulation should have been effective for about three years, when a new transplantation law 
was to be implemented. 
Supporters of a ban mainly argued with the risk of infection and pointed out the big influence 
of pharmaceutical enterprises on Parliament, explicitly Novartis.
9
 Opponents of the ban, on 
the other hand, mainly argued in terms of securing the Swiss research location, that the 
general electorate already declined total bans in the preceding biotechnology referendum 
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 The responsible Committee Social Security and Health had an expert hearing on 14.2.1999. As experts invited 
were Bärbel Hüsing (presentation of results of the study xenotransplantation of TA Swiss), Prof. Dr. Andrea Arz de 
Falco (Xenotransplantation from ethical perspective), Prof. Dr. Karin Mölling (Xenotransplantation and virology), 
Prof. Dr. Paul Herrling (Research in the area of xenotransplantation). 
8
 A compromise, which tried to accommodate the council of state by keeping the ban and alleviating the 
requirements, was declined by 77 to 72 votes (Curia Vista 1999). 
9
 For instance, the social democrat Franco Cavalli said in the plenary debate: ―The Parliamentary history of this 
federal decree resembles a cheap tragic comedy. This decree shall be effective for three years. During this time 
factually there is a global moratorium for xenotransplantation of tissues and organs. Whether there is a ban with 
possible exceptions or a strict process of authorization with strict requirements, practically this is all the same. 
Nevertheless the right in this House and particularly the lobby of pharmaceutical enterprises wanted to show once 
again who the master of the house is. The way in which this final version of the federal decree was forced is in my 
opinion an insult to reason. One has argued with the research location of Switzerland, which is ridiculous. One has 
argued against a seemingly solo of Switzerland, which is even more ridiculous‖ (Amtliches Bulletin 1999d) 
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and that no other country would have banned xenotransplantation by then.
10
 The economic 
argumentation played an outstanding and extraordinary role in the parliamentary debate and 
finally turned the governmental bill from an initial ban to permission in principle. The 
parliamentary debate on the issue can be characterized as severe, adversarial, raising 
fundamental issues, and, at times emotional. Thus, the result of the provisional regulation in 
1999 was that the Swiss regulator at least in principle took a permissive position with an 
obligation for authorization so long as certain requirements were met. 
The law was implemented by government on 23.5.2001 and came into effect on 1.7.2001 
(Eidgenössisches Department des Innern 2001). If xenotransplantation of organs, tissues or 
cells from animals are transplanted into humans, prior authorization is needed from the 
FOPH. This requirement involves a free and informed consent of the recipient about the 
relevant measures and the necessary rules of behavior (ibid, Eidgenössisches Department 
des Innern 2007). 
2.3.4.5 Transplantation Law 
As already shown, the regulation of xenotransplantation was closely connected to the 
development of a comprehensive federal Swiss transplantation law. 
Initially the discussions about transplantation and xenotransplantation were independent. In 
international comparison Switzerland regulated transplantation very late. This can be 
explained by the distinct distribution of competencies between cantons and the federation. 
The regulation of health relevant topics falls under the competence of the cantons. Cases 
where the federation has the competence according to the Swiss constitution are the 
exception to this. Transplantation did not pose such an exception and for a long time it was 
within cantonal competence, which meant that each canton had its own regulation or no 
specific legal regulation at all (Schweizerischer Bundesrat 2001). 
Attempts to develop a federal legislation date back to the mid 1980s but these were always 
pushed back. Finally, in 1993 and 1995 the Swiss Parliament accepted two motions which 
asked the government to prepare the constitutional bases for a federal transplantation law 
(Interview 4: 96-113). Motion Onken (7.12.1993) demanded the ban of commercial trade with 
human organs in Switzerland. Motion Huber (28.2.1994) demanded the creation of a 
constitutional and legal basis to cope with the manifold legal and organizational problems 
posed by transplantation medicine (Nationalrat 1996a: 2). 
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 For example Christine Egerszegi-Obrist in the plenary debate: ―Whereas the governmental draft provides an 
unnecessary prohibition and would cause negative consequences for patients and the research location 
Switzerland, the motion of the minority provides a reasonable authorization solution according to the proven 
principle ‗No bans, but yes to strict and responsible regulation‘‖ (Amtliches Bulletin 1999a). 
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These advances towards a federal transplantation law happened at around the same time as 
xenotransplantation became topical. Although it was coincidental that a transplantation law 
was being developed, it nevertheless put xenotransplantation on the political agenda 
(Interview 2: 49-57). Initially, the FOPH intended to regulate both issues in a comprehensive 
transplantation law. In the end this plan was not realized because of a motion from the 
National Council asking for a temporary regulation of xenotransplantation. As previously 
mentioned, the Federal Decree on the Control of Blood, Blood Products and Transplants 
was therefore amended with regards to xenotransplantation. 
A constitutional base was necessary in order to comprehensively regulate transplantation 
medicine on the federal level. The development of a transplantation law took several years, 
one reason being that the procedures to pass a federal law are extremely time-consuming. 
Before a law could be passed cantonal responsibilities had to be transferred to the 
federation. This implied a change of the constitution and a need for a referendum. For this to 
take place the FOPH had to draft a constitutional amendment; this went into consultation in 
autumn 1996 and, according to plans made in 1997, should have been sent to Parliament as 
a bill in the spring of 1997. It was also intended that this draft should include a final 
regulation of xenotransplantation (Eidgenössisches Department des Innern 1997b). In fact, 
the work on the actual transplantation law ran parallel to and was coordinated with the work 
on the constitutional bases for the transplantation law (Nationalrat 1996a: 2). 
In the consultation of the constitutional amendment, the Green Party and the Schweizer 
Tierschutz (Swiss Animal Protection) demanded a constitutional ban of xenotransplantation. 
The Basel Appeal demanded a moratorium until 2020 and supported its claim with a petition 
of 6,500 signees. The Social Democratic Party also demanded a moratorium 
(Schweizerischer Bundesrat n. d.: 20, Eidgenössisches Department des Innern 1997a: 19 
ff.). 
On 7.2.1999 a vast majority of the electorate was in principle in favor of regulating 
transplantation on a federal level (Monnier/Weber 2005, Schweizerischer Bundesrat 2001: 
67).
11
 Parliament was therefore able to regulate xenotransplantation on a federal level. 
The formal consultation process was carried out between 1.12.1999 and 29.2.2000 
(Schweizerischer Bundesrat 2001: 69). As already mentioned, the regulation of 
xenotransplantation, as adopted by the National Council in 1999, was criticized during the 
consultation by the majority of respondents. Many statements demanded a ban or a 
moratorium of xenotransplantation and argued with points about the risk of infection, animal 
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 Article 24 decies Fededral Constitution: I. Die Bundesverfassung wird wie folgt geändert: 1. Der Bund erlässt 
Vorschriften auf dem Gebiet der Transplantation von Organen, Geweben und Zellen. Er sorgt dabei für den Schutz 
der Menschenwürde, der Persönlichkeit und der Gesundheit. 2. Er sieht insbesondere die Unentgeltlichkeit der 
Spende vor und sorgt für eine gerechte Zuteilung von Organen. II. Dieser Beschluss untersteht der Abstimmung des 
Volkes und der Stände (Schweizerischer Bundesrat n. d.: 45). 
I H S —Griessler / PTA and Swiss Xenotransplantation Policy — 29 
 
 
protection, the violation of the dignity of the animal, uncertain medical and economical 
benefits as well as ethical concerns (Schweizerischer Bundesrat 2001: 73, 127). The 
governmental bill also refers to the results of the PubliForum and mentioned that there were 
concerns regarding the medical and psychological consequences of xenotransplantation. 
Though the PubliForum did not demand a moratorium by majority, it emphasized alternatives 
to alleviate organ shortage, e.g. by prevention of diseases which might lead to organ failure 
(Schweizerischer Bundesrat 2001: 127). Despite this critical assessment the bill proposed to 
maintain the regulation of 1999, which stipulated no ban or moratorium but rather an 
obligatory prior authorization. It did so without providing reasons for this decision (Schweizer 
Bundesrat 2001: 127, 164 ff.). The federal transplantation law was passed on 8.10.2004 and 
came into effect in 2007. After the provisional regulation in 2001 xenotransplantation was 
thereby finally regulated within the transplantation law. 
2.3.5 Federal Office for Public Health (FOPH) 
The Swiss FOPH is responsible for xenotransplantation since it concerns itself with human 
health (Interview 4: 4-9). It was also the competent authority to develop a federal 
transplantation law in the late 1990s and early 2000s. Xenotransplantation became an issue 
for the FOPH because of the general hype surrounding this technology (Interview 4: 23), the 
research results, the hopes to help patients with transplantation of tissues, cells and organs 
of animal origin and because of early regulations in the US and the UK (Interview 4: 021-
030). 
As already shown, the regulation of xenotransplantation was embedded in a longer and 
broader history of the FOPH‘s activities in the early 1990s in regulating blood safety and 
preservation as well as the transplantation of organs and tissues. However, at that point 
xenotransplantation was not an issue yet. 
This changed in the late 1990s when the question of which regulation would be applicable in 
the case of xenotransplantation in Switzerland arose. At that time it would have been legally 
sufficient to notify authorities if xenotransplantation experiments were conducted. The Swiss 
Parliament, as already mentioned, considered this situation unsatisfactory. In a motion it 
required that the government regulate xenotransplantation and make clinical trials subject to 
prior authorization. Reacting to this parliamentary motion, the FOPH initially planned to 
prohibit clinical research on xenotransplantation in general and to only allow a few 
thoroughly specified exceptions. This proposal, however, was not accepted by Parliament. 
After negotiations, a more permissive regulation was adopted that made xenotransplantation 
subject to governmental authorization. 
As already mentioned, the FOPH had to work out a comprehensive transplantation law, 
which also included xenotransplantation at about the same time (Interview 4: 37-61). 
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2.3.6 TA-Swiss 
On proposal of the government, TA-Swiss was established by the Swiss Parliament in 1992 
as then temporary Program for Technology Assessment (TA-Programm Switzerland, later 
TA-Swiss) so as to establish a system of TA tailored to Switzerland. TA-Programm should 
investigate the positive and negative consequences of new technologies, taking into account 
different aspects such as ecology, economy, the political system, culture and others. 
Moreover it should integrate already existing TA efforts in science and industry and create a 
bridge between experts in science, technology and the general public. It should also provide 
as much as possible objective and methodologically correct TA analysis (Technology 
Assessment n. d., Pfersdorf 2008: 54). 
TA-Swiss is mandated and financed by the Swiss Parliament for the purpose of carrying out 
independent TA on debated and controversial technologies, to work out recommendations 
and to organize discussions; these involve experts, different interest groups but also citizens 
(Interview 1: 65-71). In order to reach these goals, it monitors technologies rather broadly 
(Interview 5: 7-8). TA-Swiss regards itself very strongly as political consulting organization to 
Parliament and government (Interview 1: 134-135, 144-145, 158-162) and tries to take into 
account issues, which are topical on the political agenda. In comparison to other TA 
organizations, such as the Dutch Rathenau Institute or the Danish Board of Technology, they 
focus less on organizing public debates. Instead their focus is more on informing politicians 
about expert and citizen opinions on sensitive questions, with regards to technology, early on 
for their political work (Interview 1: 348-351). TA-Swiss perceives itself as a group of 
counselors, which must not replace but should instead advise, supplement and counsel 
Parliament. At times, TA-Swiss tries to do this by carrying out expert studies, at other times 
by organizing citizen conferences (Interview 1: 407-415). 
TA-Swiss is free and independent in the selection of technologies to investigate, a fact that is 
strongly emphasized in interviews (Interview 1: 154-171, Pfersdorf 2008: 54 ff.). After 
monitoring controversial technologies and deciding which of them would be of interest, the 
office of TA-Swiss, formulates project proposals to its steering committee 
(Leitungsausschuss). This governing body has to approve project proposals as well as 
budgets and the release of reports (Interview 1: 77-85, 126-128, Schweizerischer 
Wissenschaftsrat n. d., Pfersdorf 2008: 55). 
In the past a few politicians were amongst the 15 to 16 members of the steering committee. 
However, this practice stopped in 2007 when TA-Swiss was separated from the 
Schweizerischer Wissenschafts- und Technologierat, an advisory body to Parliament, and 
incorporated into the Akademien der Wissenschaften Schweiz, a research organization 
(Interview 1: 173-177). This transfer was aimed at strengthening TA-Swiss‘s independence. 
It was thereby detached from its direct connection to Swiss politicians and put at arm's 
length to government. Although Parliament retained some rights to propose topics, it is 
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basically the steering committee that has the final say on the selection of which technologies 
to investigate. In general, members of Parliament only raise a few new topics because they 
are too removed from technological developments (Interview 1: 180-182). It is the office and 
its steering committee and not public administration and politics that decide whether to 
investigate a topic (Interview 1: 209-215). 
Due to financial restrictions TA-Swiss has to look for additional funding to carry out its work 
but would only accept public money and no funds from private industry since that might 
jeopardize their trustworthiness (Interview 1: 200-206). 
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3 Technology Assessment 
TA-Swiss did not receive a political order to carry out its TA on xenotransplantation. It was 
the office of TA-Swiss itself that proposed this activity to its steering committee. It took this 
initiative because it perceived xenotransplantation as an up and coming biomedical 
development the social and ethical impact of which would need closer scrutiny. One of the 
events triggering TA-Swiss's interest were reports of British based Imutran's activities in this 
field (Interview 1: 91-92) and Sandoz's market study (Laing 1996) predicting a huge increase 
in xenotransplantation within the next decade. Although in hindsight TA-Swiss did not take 
Sandoz‘s predictions at face value already by that time, they regarded xenotransplantation 
as an up and coming topic that would potentially require TA so long as there was still space 
for political action and maneuver (Interview 5: 8-16). 
In one interview partner‘s recollection, Sandoz's brochure was quickly followed by reactions 
from Swiss NGOs such as the Basel Appeal, studies by the US-American Institute of 
Medicine, the British Nuffield Council and the German European Academy. The WHO also 
started to deal with the topic. In hindsight, one main impetus for investigating 
xenotransplantation was TA-Swiss‘s observation that the actors opposing 
xenotransplantation started to mobilize; these argued that it would be unethical, risky and 
only for the profit of industry (Interview 2: 25-34). The steering committee agreed with the 
office‘s plan rather quickly (Interview 5: 106-113). 
In a one-page background paper, the call for tenders for a TA study on xenotransplantation 
argued for TA: They mentioned the societal and ethical aspects of this technology, the Basel 
Appeal‘s call for a moratorium and quoted Florianne Koechlin‘s concerns of xenozoonosis 
(Schweizerischer Wissenschaftsrat 1996b). They also quoted ethical concerns about using 
animals as spare part warehouses for humans and referred to the public controversy about 
the use of primates for research. Moreover, the call for tender under the heading of 
economical aspects quoted Salomon Brother‘s study which predicted a huge increase of 
revenues because of xenotransplantation and also referenced Sandoz/Novartis activities in 
this area. Finally, the paper quoted the parliamentary initiative and interpellation of Margrith 
von Felten in which she put xenotransplantation on the agenda of Parliament (see above; 
see also Bellucci et al. 1998: 156). 
TA-Swiss is a small organization, staffed with six to seven people (Interview 5: 123-124 
Schweizerischer Wissenschaftsrat n. d.). Therefore in general it contracted out its TA studies 
to competent research organizations. Moreover, it does not have the necessary and specific 
expertise in each and every technology field (Interview 126-132, Schweizerischer 
Wissenschaftsrat n. d.). 
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After an open and international call for tender, TA-Swiss contracted FhG-ISI, a German 
research institute based in Karlsruhe, to carry out a TA study on solid organ 
xenotransplantation (Hüsing et al. 1998). The TA study was to provide an overview on the 
international state of the art of xenotransplantation and its positive and negative 
consequences from societal, ethical-anthropological, economic and clinical perspectives. In 
particular, it should emphasise the Swiss situation with regards to acceptance of 
xenotransplantation and regulatory questions (Schweizerischer Wissenschaftsrat 1996a). 
FhG-ISI did a typical TA study. They analyzed literature and did interviews with stakeholders, 
ranging from animal welfare activist organisations, concerned patients and physicians to 
associations, both for and against xenotransplantation. However, the study also included 
several elements of invited participation (Hüsing et al. 1998: 9 ff.; 231): 
First, as already mentioned, 18 in-depth interviews were carried out with Swiss experts from 
the fields of industry, medicine (surgery, transplantation, veterinary medicine, virology, 
preventive medicine, and professional organizations), law, patient associations, and 
social/critical organizations (Bellucci et al. 1998: 157). 
Secondly, organized stakeholders were also asked to answer seven questions about their 
position on this technology in writing which, so as to allow for framing of xenotransplantation 
by the respondents, were deliberately formulated rather openly and qualitatively (Hüsing et 
al. 1998: 232). 
The following questions were asked: (1) Is xenotransplantation an issue of relevance for your 
organisation? Why? How important is it for your organisation? (2) To which extent have you 
been occupied as organisation with xenotransplantation? (3) What are the most important 
aspects from your perspective? (4) What are the results of your considerations? Why? 
Which aspects did your organisation not evaluate conclusively? (5) In which way do you 
want to deal with xenotransplantation in future? (6) What measures are needed? (7) Which 
measures are necessary and suitable to lead to a public discussion of xenotransplantation 
(Hüsing et. al. 1998: 11)? 
The stakeholders included a very broad range of organisations including political parties, 
research funding organisations, obligatory health insurances, interest organisations of health 
care professionals, scientific associations, animal welfare activists, NGOs critical of 
biotechnology and churches (Hüsing et al. 1998: 234). 
A total of 145 organizations had been addressed. 77 (53%) did not reply and 68 institutions 
replied (47%). From organizations which replied, 14 stated that xenotransplantation was not 
relevant for them, 19 wrote that the issue was not relevant but forwarded the letter to 
concerned organizations. Finally, 34 organizations gave a statement, i.e. 23% of those 
initially addressed (Hüsing et al. 1998: 12). 
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An interviewed TA-researcher argued that it was unavoidable in TA on new and emerging 
fields to ask experts and stakeholders their opinion because otherwise it would be 
impossible to get the necessary information. Moreover stakeholders can provide a basis for 
feasible recommendations, which, in contrast to ivory tower philosophy, are imperative for 
TA (Interview 2: 96-102). In other words in order to produce useable recommendations the 
involvement of stakeholders was necessary. 
The report was published in August 1998 and took a cautious approach towards 
xenotransplantation. A cautious call for a moratorium was also debated in the aftermath of 
the TA study. Opponents of a moratorium argued that such a ban, which would also prohibit 
basic research, would make it impossible to study the problems associated with 
xenotransplantation. Advocates argued that only a moratorium without loopholes could 
ensure that a really open dialogue took place in public (Newsletter TA-Programm Schweiz 
1998: 3). 
This study was followed by a TA on cellular xenotransplantation (Hüsing et al. 2001). 
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4 PubliForum 
After TA-Swiss had finished its TA on solid organ xenotransplantation and had disseminated 
its results to politicians, administration and the public
12
 by publishing a long and short version 
of the report (Hüsing et al. 1998, TA Programm Schweiz 1998) and presenting it to the public 
(Technologiefolgenabschätzung 1998, Technology Assessment 1998), they thought about 
how to proceed with the topic of xenotransplantation (Interview 9: 005-007).
13
 As an 
interview partner stated, because TA-Swiss believes that it is important to inform politicians 
and citizens about what experts think as well, they go beyond classical expert TA in cases 
they consider important (Interview 1: 131-135, ZTA et al. 2001: 4). TA-Swiss decided that a 
PubliForum might be a sensible way to proceed with the topic and to thereby re-use the 
results of the TA (Interview 5: 270). But there were also other organizations, which 
considered a PTA valuable: 
 From the TA study it emerged that it was unlikely that public discourse on 
xenotransplantation might yield consensus given the incompatible positions on 
xenotransplantation. In the opinion of the authors of the TA study, much could be 
gained if escalation was avoided. To achieve a rational debate, the discourse was to 
be initiated and furthered rather than left to its own resources, e.g. by measures 
tailored to specific target groups using brochures, media reports, presentations and 
discussions for professionals, multipliers and interested citizens. The TA study 
already argued for a citizen panel or consensus conference, which might be carried 
out in the context of the pending regulation of transplantation medicine. The results 
of such an event should be appropriately considered in the political decision making 
process (Hüsing et al. 1998: 178, Bellucci et al. 1998: 165). 
 The FOPH considered transplantation medicine a well-suited topic for trying out the 
Danish consensus conference model in Switzerland, an idea, which was also 
supported by the responsible minister. In a documentation the FOPH department of 
law refers to the TA study by stating that the authors recommend a societal opinion 
formation process with regards to xenotransplantation and transplantation medicine 
(―Verfassungsbestimmung über die Transplantationsmedizin‖ Chapter 5.9) TA-Swiss 
organized the PubliForum together with FOPH and the Swiss National Fund (SNF), 
who at that time had a funding program on transplantation medicine, (Interview 4: 
185-202). 
 In 2000 the Swiss Academy of Medical Sciences claimed that ―the organization of a 
‗public forum‘ could be useful to open the debate‖ on the ―aims of allogeneic and 
xenogeneic transplantations and on other potential solutions for the problem of the 
                                                     
12
 In its newsletter TA Swiss reports in September 1998 that it presented the TA Study on 7.9.1998 in an event which 
was attended by more than 100 people. They also mentioned that print media and the radio programmes DRS and 
RSR reported this event (Newsletter TA-Programm Schweiz 1998: 3). 
13 
TA Swiss monitored the impact of the TA and reported to its Steering Committee (Technology Assessment 1999). 
The impact mentioned in this paper is a press release by the Federal Office for Public Health, a reference in the 
German TAB and an OECD document which reports about the TA study on xenotransplantation (Interview 467-474). 
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shortage of donor organs‖. In this discussion ―the costs and the benefit for the 
patient and for society (…) as well as the ideological differences existing within the 
general population‖ (SAMW 2000: 392) should be debated. 
 
The PubliForum on transplantation medicine was not to the first to be organized by TA-
Swiss; the PTA was preceded by two PubliForums on energy policy and genetically modified 
organisms. TA-Swiss learned two lessons from these exercises as well as from international 
comparative research on PTA. Firstly, that strong expertise in the topic addressed was 
needed and, secondly, that the PubliForum should be connected with an actual political 
decision. Recognizing these two lessons, TA Swiss reused the knowledge and expertise 
gained in the TA. It placed the topic of xenotransplantation in the wider context of 
transplantation medicine, which was at that time discussed in the context of the imminent 
transplantation law. The PubliForum therefore became connected to an ongoing regulative 
initiative (Interview 1: 225-33) and xenotransplantation became one among six areas which 
were discussed in the PubliForum (Interview 5: 285-291). By creating this connection and 
involving the FOPH
14
 as well as the Swiss National Science Foundation
15
 as co-organizers, 
TA-Swiss not only strengthened the PubliForum‘s link to the policy making process and 
research but also to its financial bases for the PTA. 
4.1 Aim 
The TA-experts interviewed stressed that it is not the goal of a PubliForum to make a binding 
decision on a technology but rather to inform politicians about citizens' opinion early on. A 
PTA deals with complex issues, which pose challenges to both politicians and the electorate. 
It is an early process in which citizens are informed about the issue at stake. PTA provides a 
means for an organized and informed debate and a possibility to uncover certain aspects 
important for the citizens but which legislators may overlook. This may happen not because 
legislators are stupid or evil but because experts, jurists and university graduates were 
dealing with these issues from a specific level and angle (Interview 5: 398-403). 
Several TA-experts stressed the term qualitative when they described the PubiForum. It is 
not the goal of a PubliForum to provide a representative picture of what the Swiss population 
thinks about a topic but it is a qualitative process, which results in a report about what 30 
Swiss citizens think. These did not know each other before and were informed by experts 
with whom they spoke in the PTA. After a total of eight days people are quite informed about 
a topic and the resulting reports are of good quality. A PubliForum is a qualitative process, 
which can become one element in the larger mosaic of the political process; this may result 
in a law or referendum (Interview 1: 377-398). Another TA-researcher emphasised that it 
                                                     
14
 One civil servant was member of the Advisory Committee, two in the organisation group (ZTA et al. 2001: 86) and 
one as informant in the PubliForum (ZTA et al. 2001: 65 ff.). 
15
 The SNF at that time had a national research program on transplantation research called ―Implantate und 
Explantate‖ (NFP 46) (ZTA 2001: 4ff.). 
I H S —Griessler / PTA and Swiss Xenotransplantation Policy — 37 
 
 
was interesting for TA-Swiss not to hear a "yes or no" but to qualitatively learn what people 
think about certain issues and to hear their arguments (Interview 2: 394-396). 
One TA-researcher pointed out the difference between a referendum and a PubliForum. The 
popular referendum is organized at the very end of the process; it is about "yes" or "no" and 
results in a "yes" or "no". A PubliForum, on the other hand, is not about being for or against 
xenotransplantation but about investigating the opinions on xenotransplantation. It is a 
qualitative process in which new ideas might also develop (Interview 9: 387-393, see also 
ZTA et al. 2001: 4). 
As one scientist explained, the goal of the PubliForum was to make the public aware of the 
topic and to get a non-expert opinion from a kind of lay jury that listened to and questioned 
experts. Moreover, in the context of a xenotransplantation regulation, one aim was to get a 
feeling for what the public thought of xenotransplantation after being informed (Interview 6: 
056-068). 
4.2 Process 
The PubliForum was modeled on the Danish consensus conference (ZTA et al. 2001).
16
 In 
April 2001 about 10,000 randomly selected Swiss residents were contacted, provided with 
information about the planned PubliForum and invited to participate. Interested citizens could 
apply by filling out a short biographical questionnaire. Out of 100 persons who registered, 28 
were selected so as to obtain a heterogeneous sample of age, sex (50% male, 50% female), 
profession, and linguistic region (Bütschi n. d.).
17
 
At the beginning of the PubliForum the lay panel studied fact sheets on transplantation 
medicine. These were produced by a science journalist and sent to the panel before the 
actual events. The citizens subsequently met on two weekends in September and October 
2000. On the first weekend they were introduced to the concept of a PubliForum and, after 
input from experts, discussed medical, ethical and legal aspects of transplantation medicine. 
It was also considered which questions to address in the public event. 
On the second weekend the lay panel decided on which issues they wanted to continue to 
discuss in the public hearing. These topics were that of a definition of death, perspective of 
those concerned, allocation of organs, regulation of organ donation, research and 
xenotransplantation (ZTA et al. 2001). The lay panel also selected which experts they 
wanted hear from on these questions. For that purpose TA-Swiss put together a list of about 
90 experts, with backgrounds ranging from ethics to medicine, from which lay citizens had to 
                                                     
16
 ―The TA-Programme developed a slightly modified form, which are adapted to Swiss multilingualism. To avoid the 
misunderstanding that the exercise‘s primary goal was be to reach consensus, it calls this approach PubliForum‖ 
(Schweizerischer Wissenschaftsrat n. d.). 
17 
For a participant list see ZTA et al. 2001: 11 ff. 
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make their choice.
 
The experts invited to cover the topic of xenotransplantation were Bärbel 
Hüsing (biologist, main author of the TA study on xenotransplantation, FhG-ISI), Richard 
Friedli (religious study, University Fribourg) and Florianne Koechlin, (biologist, Schweizer 
Arbeitsgruppe Gentechnologie). 
The PubliForum took place from the 24. to the 27.11.2000 and was organized as a two-day 
public discussion with experts on the six selected topics. With respect to xenotransplantation 
the citizen panel posed several questions to their informants (ZTA et al. 2001: 78ff.): 
 How do you evaluate the health risks, benefits and ethical consequences of 
xenotransplantation? 
 How can these health risks be identified and prevented? 
 Which alternatives to xenotransplantation exist and how do you evaluate them? 
 
The public discussion with experts was followed by a day for citizens to produce their report 
in discussions closed to the public and a concluding day for the lay panel to present its report 
to the public (ZTA et al. 2001). 
To write their recommendations the lay panel formed working groups which, to facilitate 
discussion, were homogenous concerning language. Each group had to produce 
recommendations on one topic. TA-Swiss provided a template of how to structure this report: 
first, a summary was needed of what the lay citizens had learned during the process in terms 
of content; second, the citizens should present their opinion and, third, recommendations. 
The recommendations should be as explicit as possible about to whom they are addressed 
and should be formulated as clearly as possible. Work in groups alternated with plenary 
discussions. 
The PubliForum was facilitated by a trained moderator whose aim it was to achieve a 
consensus within the group (ZTA et al. 2001: 6). As a TA-researcher explained, the idea of 
the PubliForum was not to stimulate a vote with majority and minority positions as it is 
usually the case in political arenas (for instance a parliamentary commission), but to 
generate ideas and recommendations shared by the group. However, this was not always 
possible and if consensus was unattainable there was always the possibility of a vote (ZTA 
et al. 2001: 8). This happened in the case of xenotransplantation; while the majority 
considered the regulation proposed by the FOPH as sufficient, a minority favoured a total 
ban or moratorium (Interview 9: 174-201). 
In a public presentation the citizen panel passed its report to the heads of the responsible 
parliamentary commissions of the National Council and the Council of States. These 
members of Parliament were ―very interested in the results‖ and invited the lay citizens to 
meetings of their commissions. The responsible civil servant of the FOPH also thanked the 
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citizens and stated that their results would be taken into consideration in the development of 
the transplantation law (ZTA et al. 2001: 9). 
4.3 Output 
In their statement the citizen panel summarized the responses of the informants as follows: 
If xenotransplants became an adequate alternative to human grafts their benefits would 
include: that there would be sufficient organs for transplantation, the allocation of organs 
would only be based on medical criteria; elective surgery with better prospects would be 
possible, recipients would no longer have to feel a sense of guilt towards their deceased 
human donors, the bases for organ trafficking would be weakened, even if 
xenotransplantation were only be used as bridging solution it would be possible to save 
human lives. 
Health risks would include: a risk of infection with unknown diseases, stronger 
immunosuppressive drugs would be needed, knowledge about long term functioning of 
animal organs is lacking, known psychological problems for recipients might be aggravated 
and new problems might arise, the chance of psychological rejection due to cultural or 
religious reasons has to be investigated. Because of these risks a number of informants 
demanded a moratorium for xenotransplantation. 
Ethical considerations involved: the question of whether we are allowed to degrade animals 
to spare part storages, the fact that in certain religions the pig is considered as impure and 
that a bridging solution would only further increase organ shortage. One informant also 
considered the spread of animal cells in the human body as problematic. 
So as to minimize further risks, animals can be raised in sterile conditions and tested for 
known pathogens. Nevertheless, it cannot be excluded that unknown pathogens are present. 
Animals can also be modified genetically to suppress rejection. 
Alternatives to xenotransplantation include prevention, increasing the readiness to donate 
and to promote living donation. Alternative technologies, which were promising in the long 
term, (requiring approximately the same time to develop) were: artificial organs, research 
into the causes of organ failure, tissue engineering, and stem cell technology. 
The citizen panel came to the opinion that the risk of infection involved was not only a 
problem for the recipient but for the entire population and that retroviruses could cause 
diseases that might spread epidemically. Furthermore, the panel considered the 
transgression of the species boundary as problematic and concluded that psychological 
problems must on no account be underestimated and trivialized. The benefits, as reported by 
experts, would not outweigh the great risks of xenotransplantation by far. The lay jury 
I H S —Griessler / PTA and Swiss Xenotransplantation Policy — 40 
 
therefore especially emphasized alternatives named by experts. A significant majority of the 
panel supported the statement that the breeding conditions of ―source animals‖ would not at 
all meet requirements of species-appropriate animal husbandry. Genetic modification on 
pigs, which would be necessary to reduce rejection, was considered ethically questionable. 
The panel also stated that it did not think that an animal might be degraded to a spare part 
stockroom. 
5 citizens voted for a moratorium on all xenotransplantation research and another 5 opted for 
a moratorium on clinical research. However, a majority of 14 people were not in favor of any 
form of a moratorium because they considered the legal requirements as sufficient. 
In its recommendations, the citizen panel stated that they would call attention to alternatives 
to xenotransplantation to alleviate organ shortage. In particular prevention should be 
intensified and legal regulations for living donation should not be formulated too restrictively. 
Additionally, research into artificial organs, organ failure and tissue engineering should be 
supported and intensified. 
Finally, the regulations proposed in the government bill regarding xenotransplantation and 
clinical trials were considered sufficient; a majority was therefore not in favor of a 
moratorium. However, liability regulations should be formulated more strictly (limitation and 
insurance). A paragraph is also missing which requires the written consent of a 
xenotransplantation recipient (ZTA et al. 2001: 32 ff). 
4.4 Advisory Group 
TA-Swiss technology assessments are routinely accompanied by a so-called advisory group 
(Begleitgruppe) (Interview 9: 60-63) that brings together members of TA-Swiss‘s steering 
group and independent experts (Technology Assessment n. d.). This covers topics rather 
broadly (Interview 5: 132-134) and has two intertwined goals: (1) to provide quality 
assurance; (2) to create legitimacy by involving stakeholders 
As one interview partner explained, the advisory body legitimates the TA process and its 
output. It does so by the fact that a broad spectrum of institutions and people concerned with 
the issue at stake were involved in and consented to the study (Interview 2: 249-257). 
Furthermore, it increases the credibility of the TA by assembling the best competencies 
(Interview 4: 139-145). Another interviewee described the advisory group as a tool for 
tapping into the TA people‘s scientific, political, regulatory and ethical expertise (Interview 8: 
251-264). The advisory group was also a quality assurance tool since TA-Swiss‘s staff 
cannot provide expertise on all topics. 
Besides providing credibility in terms of content, the advisory group should also safeguard a 
TA‘s political acceptability by avoiding one-sidedness (Interview 4: 505-523). By setting up 
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an advisory group and involving influential and concerned groups, TA-Swiss tries to embed 
the TA in the respective policy field. 
The TA study on xenotransplantation and the PubliForum were both accompanied by an 
advisory group. The advisory group of the TA study included two ethicists, a jurist, a Member 
of Parliament (who was also on the board of Basel Appeal), a surgeon, a civil servant from 
the FOPH and representatives of compulsory health insurance, Novartis, a self help group of 
kidney patients and the steering group.
18
 
Participation in the advisory group can also be understood as a matter of politics and as a 
strategic decision. One interview partner, for example, criticised the involvement of Novartis 
given their interest in xenotransplantation. To provide another example, Basel Appeal 
perceived its participation strategically. It provided valuable information, which Basel Appeal 
would not have been able to access had they refused participation (Interview 3: 374-175). 
The NGO planned to leave the advisory group with an uproar, if the TA were to be one-sided 
and characterized by interests; because their member felt that her political and critical 
opinions were taken seriously by the contractor of the TA study this never happened 
(Interview 3: 354-355). Actually, it seems that Basel Appeal was quite pleased with the TA 
results; a circular reads: „With great satisfaction the five authors (of the TA, EG) practically 
arrived at the same conclusions as we did‖ (Basler Appell 1998). 
Regarding the proceedings, the advisory group worked in meetings. In a kick-off meeting 
FhG-ISI presented its planned approach to the study. The advisory group was able to make 
suggestions and ask for amendments to the proposed TA approach. It was not entitled to 
ask for a complete and fundamental change though. During the project‘s lifetime the advisory 
group met several times and discussed interim and final drafts of the TA (Interview 4: 170-
18, Interview 3: 237-239). 
In the PubliForum the advisory group consisted of representatives from research, politics, 
industry, public administration and NGOs.
19
 It was to safeguard transparency and objectivity 
but also decided on the final composition of the citizen panel. It helped organizers identify 
                                                     
18
 Members of the advisory group were PD Dr. Alberto Bondolfi (ethicist/theologian, University Zürich), Prof. Marco 
Borghi (jurist, University Fribourg), Margrith von Felten (Member of Parliament), Dr. Reto Guetg (physician, 
Konkordat der Krankenkassen), PD Dr. Detlef Niese (physician, Novartis), Andrea Schäfer (Association of Kidney 
Patients of Switzerland), PD Dr. Rolf Schlumpf (transplantation surgeon, Kantonalspital Aarau), Dr. Theodor Weber 
(FOPH). As representative of the steering committee: Prof. Thomas Leisinger (microbiologists, ETH Zürich) and 
Prof. Hans-Peter Schreiber (ethicist, ETH Zürich, ZTA et al. 2001). 
19
 Members of the advisory group in the PubliForum were: Andrea Arz de Falco (Präsidentin der Ethikkommission 
Gentechnik im ausserhumanen Bereich), Daniel Candians (Queen Elizabeth Hospital, Birmingham, UK), Conrad 
Engler (Interpharma), Pierre-Alain Gentil (Ständerat), Werner Losli (Ehrenpräsident der Patientenorganisation ‚As 
de Coeur―), Francois Mosimann (surgeon, representative of Swiss Transplant), Catherine Nissen-Druey (Swiss 
Council for Science and Technology), Kurt Seelmann (jurist, University of Basel), Rosemarie Soldati (former 
member of Council of State), Verena Soldati (Basel Appeal), Thomas Szucs (health economist, University Hospital 
Zürich), Rosemarie Waldner (journalist, member of the Steering Committee, ZTA), Theodor Weber (FOPH), Bianca 
Witvilet (Swiss Association of Nurses and male Nurses) (ZTA et al. 2001: 85). 
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experts for the list of informants from which the lay panel had to select and recommended 
experts to the lay citizens. They also provided topics for the preparatory fact sheets (ZTA et 
al 2001: 6 ff.). 
4.5 Difficulties 
Drawing from the interviews there were only a few problems during and after the 
PubliForum. The most important problem was related to the connection between the 
PubliForum‘s output and the policy making process. It turned out to be difficult to 
synchronize these two processes (Interview 9: 109-114). Initially the organizers planned to 
hold the PubliForum during the consultation of the transplantation law so as to incorporate 
the lay panel‘s opinion into the government‘s bill. However, due to timing problems this plan 
was not realized. As already mentioned, the lay panel was aware of and in majority explicitly 
agreed with the FOPH's restrictive position (Interview 9: 202-207). 
Recruitment of the lay panel was not a problem then. Nowadays it is more difficult to get 
participants other than people over fifty to attend. However, by definition, the composition of 
such pTA groups should consist of different occupations, formal education, ethnicity, age 
and gender. Thus, today TA-Swiss is therefore thinking about providing compensation as an 
incentives to participate. (Interview 2: 353-358). 
One TA-researcher considered the process of putting together an extensive list of different 
experts for the lay panel to select informants from as most difficult and time consuming. An 
advantage of this procedure is that citizens sometimes select unorthodox experts who 
perceive a topic from a new and different angle in contrast to those experts regularly asked 
for statements. However, because the process of putting together such a long list is so time-
consuming, TA-Swiss nowadays selects the experts themselves. 
The common problem for PTA of a knowledge asymmetry existing between experts and 
laypeople also occurred in the PubliForum. However, according to a TA-researcher the 
experts were ready to express themselves in a way that laypeople were able to understand 
(Interview 5: 362-367). Another interview partner thought that the gap between experts and 
laypeople was softened since the citizen panel was informed about rejection mechanisms, 
viruses, infections and ethical problems beforehand (Interview 6: 356-361). 
4.6 Representation of man and women in the PTA 
Regarding questions of gender, the number of male and female participants in the 
PubliForum was equal (14/14). A professional moderator was responsible for ensuring that 
men and women had an equal opportunity to contribute to the discussions (Interview 9: 259-
261). In the advisory group there was a slight male majority of 8 men to 6 women and the 
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invited experts who informed the lay panel about xenotransplantation included two women 
and one man. 
4.7 Experiences 
Almost all interviewees had very positive experience of the PubliForum. According to a 
participating scientist the lay panel was very interested, raised good questions and was very 
knowledgeable after the two weekends of teaching. The PubliForum was a good way to 
discuss the topic rationally and provided a good link between the public and science: 
“I thought this was great. (...) From my perspective this was an opportunity to really involve 
the public and inform them in depth, to organize a contact and link with science in a close 
and deep way. It creates a really good dialogue. If we could do this more often, particularly in 
technology assessment, it is really an opportunity to find out what people want and on the 
other hand to directly inform them on: „what the risks are, what the benefits are of a 
technology and to do that rationally, properly without an underlying idea to profit” (Interview 
6. 254-263). 
According to another participating scientist the PubliForum was performed in a way, which 
acted against a dynamic of polemic on the one hand and overrated hopes and prophecies on 
the other. This was attained by sombrely looking at an issue without falling into any conflicts. 
He considered this approach as typically Swiss (see below). Researchers did not 
characterize counterarguments as nonsense and ethical rubbish. Green politicians as well as 
animal welfare activists did also not take radical positions in his view (Interview 8: 181-195). 
A xenotransplantation researcher, who participated in the PubliForum as a spectator, 
described his experience as positive in an article and claimed that it would contribute to a 
serious and factual debate (Seebach 2001: 17). 
Civil servants also recalled having had positive experiences with the PubliForum. They 
described their engagement with transplantation medicine during the development of a law 
as an intrusion into a closed caste of transplantation surgeons. These accused them of 
hindering a life saving technology by taking a regulatory approach emphasizing law, limits 
and legal certainty. Transplantation surgeons demanded a law that focused on facilitating 
instead of hampering transplantation by means of what they considered as overregulation. 
Feeling uncomfortable with this situation the PubliForum gave civil servants an opportunity to 
learn what ordinary citizens and laypeople thought about transplantation. The PubliForum‘s 
results supported their policy approach of introducing control mechanisms into 
transplantation and increasing transparency (Interview 4: 203-227, 244-247). 
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4.8 Impact 
The question of what impact the PubliForum made on policy making is difficult to answer. 
The PTA certainly had some impact because the PubliForum and its results were noticed by 
relevant actors. Both the TA and the PubliForum were connected to the policy process since 
civil servants and politicians were in the advisory group (Interview 2: 199-209, Interview 9: 
223-224) and since its results were presented to policy makers, both from the executive and 
legislative. Both were at that time dealing with the development of transplantation law, which, 
as previously mentioned, was to include a xenotransplantation regulation. This follows TA-
Swiss‘s aforementioned policy to analyse and discuss technologies that are topical on the 
political agenda. Placing TA and PTA processes at the early stages of regulatory processes 
as well as involving and informing policy makers about their results increases the chances of 
these making an impact on the political system (see also: Pfersdorf 2008: 66). 
A press release from May 2001 provides evidence that the FOPH noticed the PubliForum. 
The office reported the implementation of the xenotransplantation regulation and referred to 
the PubliForum. It mentioned that the lay panel was concerned about the medical and 
psychological consequences of xenotransplantation and that they did not demand a 
moratorium but instead strongly emphasized alternatives to xenotransplantation so as to 
alleviate organ shortage (Eidgenössisches Department des Innern 2001). 
The PubliForum was also mentioned in the governmental bill, the so-called message 
(Botschaft) sent to Parliament. The message includes the history and main arguments for 
and against a bill as well as its proposed formulation. It is also the main basis for political 
debate in parliamentary commissions and the plenum (Interview 1 151-154, Interview 9: 214-
219). An entire section of the message was dedicated to the PubliForum (Schweizerischer 
Bundesrat 2001: 74 ff.). It describes the PubliForum in detail; its aim, process and main 
points of discussion. It refers to the citizen‘s report and summarizes its recommendations. 
The message states that the PubliForum had an impact because the government wanted to 
―handle the regulation of xenotransplantation restrictively‖ (Schweizerischer Bundesrat 2001: 
75). The document concludes that ―the PubliForum documented that so called lay persons 
are ready to look into a complex issue, to discuss with experts at a high level, to insist on 
delicate issues without timidity, to produce an outstanding final report in due time until the 
early morning hours and to wittily present it at a public event‖ (Schweizerischer Bundesrat 
2001: 76). TA-Swiss was actually surprised by the extent to which the results of the 
PubliForum were reported in the message (Interview 9: 223-224). 
At the same time the direct impact of the PubliForum on political decisions is hard to pin 
down because the initial plan to base the governmental bill on the PubliForum‘s output was 
not accomplished due to timing problems. When the PubliForum started (24.11.2000), the 
consultation of the bill was already finalized and the results were published in November 
2000 (Interview 4: 305-314, Schweizerischer Bundesrat 2001: 70). On 22.11.2000 the 
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Federal Council ordered the responsible ministry to work out a draft bill based on the results 
of the consultation process (Schweizerischer Bundesrat 2001: 73). 
Because the PubliForum‘s recommendation did not contradict the ministry‘s position it is 
hard to see whether it made a difference. It referred to the FOPH‘s bill and, in majority, 
considered it as sufficient. Basically, the FOPH had already made up its mind before the 
public plenum of the PubliForum (Interview 4: 285-287) and there was no need to change 
the regulation since the PubliForum shared their view (Interview 4: 293-304). An interviewed 
TA-researcher therefore considered the impact of the PubliForum as legitimizing (Interview 
9). 
Turning away from this ―hard‖ understanding of impact to wider notions of the term the 
PubliForum certainly can be regarded as having made an impact (see Versteeg/Loeber 
2011). 
PTA provided an opportunity for state and non-state actors to make (aspects of) the issue 
known to a broader audience that previously wasn't aware of it (Versteeg/Loeber 2011). An 
important prerequisite for impact, as explained by one TA researcher, is that people know 
about the PTA. In her view it was therefore necessary to organize a public event and to invite 
a broad range of people. (Interview 9: 165-166). TA Swiss therefore took particular care to 
disseminate and diffuse the results of the PTA to various audiences. The final event was 
open to the public and the results were presented to members of Parliament as well as to 
civil servants of the responsible ministry. Furthermore, the results were also published and 
sent to Parliament (ZTA 20011). 
Another notion of impact is brokerage, in the sense that an active connection is made 
between two (or more) previously unconnected social sites or actors and actor groups 
(Versteeg/Loeber 2011). PTA certainly had an impact in this sense. The setting of the 
PubliForum allowed advocates and opponents of xenotransplantation, invited as experts, to 
exchange their views. Moreover, lay citizens were informed about xenotransplantation and 
were thereby enabled to form their own opinion. Connections were also created between the 
PubliForum (in terms of results) and the actors normally involved in law making, i.e. the 
Parliament and the FOPH. It was particularly important for the FOPH, who also sponsored 
the PubliForum, to get a public opinion on the issues of transplantation and 
xenotransplantation because it was in conflict with experts about its cautious approach. So, 
for the FOPH it was an instrument for incorporating ―public‖ input into lawmaking. The results 
of the PubliForum were also noticed by Parliament since they were reported in the message. 
Moreover, the PubliForum created an opportunity for citizens to engage in the topic and for 
advocates and opponents (also from civil society) to present their positions and discuss the 
issue. 
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The PubliForum also had an impact because in the context of Swiss direct democracy and 
law making, the PubliForum was considered as an additional valid instrument for learning 
about public views on controversial scientific issues. 
The PubliForum also contributed to the policy process because the FOPH thereby felt 
strengthened in its cautious approach in relation to transplantation surgeons. But there were 
also other impacts of the PubliForum. For example, one individual hospital started providing 
psychological care in transplantation medicine. 
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5 Social Practices 
The following description of the Swiss political system is taken from a brief portrayal in 
Pfersdorf (2008: 44-48). The political practices sketched in this section have been identified 
in the interviews carried out during research. 
5.1 Social Practices in the Field of Policy Making 
The Swiss political system is located between a presidential and parliamentary system. The 
government, or Federal Council (Bundesrat), consists of seven members who as a collective 
form the head of state. The two chambers of Parliament, Council of State and National 
Council, annually elect one member from the Federal Council as head of state (Federal 
President, Bundespräsident), who only has coordinative functions. 
5.1.1 Government 
Government has a strong and independent role from Parliament. Federal Councillors are 
elected for four-year terms and cannot be deselected, whereas re-election is possible. The 
composition of the Federal Council is governed by the so-called magic formula 
(Zauberformel) which, according to a fixed key, determines how seats are allocated to 
parties since 1959.
20
 Parties adhere to this very slowly changing distribution of power, which 
is not dependent on the latest election results. Thus the system only accommodates only 
slowly, with some time delay and only after major shifts in election outcomes. The magic 
formula not only recognizes the long-term relative strength of political parties in the political 
system but is also a compromise between different political parties, Swiss ethnicities 
(German, French, and Italian), confessions and gender. Though Parliament often asks 
government to take regulatory steps by means of motions (see below), it is the Federal 
Council that prepares laws and has a main role in law making. 
5.1.1.1 Political Practices of Government 
During the law making process government prepares a draft law and sends it into a formal 
consultation process (Vernehmlassungsverfahren, see also Linder 1999a: 470). In this 
procedure stakeholders can express their opinion about a bill and propose changes 
(Interview 3: 429-437). The call for a consultation process is published. For each policy field 
different lists exist of who to involve in this process. Government addresses the so-called 
invited parties; such as the 26 cantons, other ministries, representatives of interest groups 
and other interested associations. (Interview 5: 392). However, consultation is also open to 
so-called uninvited parties, which in the case of xenotransplantation were critical NGOs. In 
                                                     
20
 The rioseof thepopulist conservative SVP since the 1990s changed the distribution of government seats for some 
time but so far did not lead to the abandonment of the concordance system (see Appendix). 
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principal the consultation is open to each citizen, though judging from the interviews this 
seems to be little known and made use of (Interview 8: 212-226, Interview 5). If a 
governmental bill is opposed by too many relevant actors, it is changed by the responsible 
ministry. An interviewed politician considered the consultation a good procedure in which 
concerned organizations can make suggestions, which are often also taken into account 
(Interview 3: 515-519). Another purpose of the consultation is to avoid referenda (see 
below), which might cause a defeat of government by voters. 
After the responsible ministry has taken into account the statements of invited and uninvited 
parties and redrafted the bill, the Federal Council sends its bills as a so called message 
(Botschaft) to Parliament. Only then does Parliament start its process of discussing and 
formulating the law in its respective commissions. 
The message is a comprehensive text, which includes the bill and background information 
on the proposal. In the case of the Amendment on the Federal Decree on the Control of 
Blood, Blood Products and Transplants, for example, the message is a well-arranged 28 
page document, which in detail analyses the development of xenotransplantation, medical 
aspects (rejection, infection, physiological compatibility), ethical aspects, preceding 
parliamentary initiatives, current Swiss and international regulation (Council of Europe, 
WHO, OECD, UK, USA), conclusions, results of consultations, an explanation of the bill, 
forecasts of consequences regarding finances and personnel, consequences related to 
European Union and the Council of Europe and, finally, the bill itself (Bundesrat 1998). The 
message on the transplantation law is more than 200 pages booklet (Schweizerischer 
Bundesrat 2001). The bill therefore included a clear and highly qualitative regulatory impact 
assessment. 
5.1.2 Parliament 
The Parliament, the Federal Assembly (Bundesversammlung), consists of the National 
Council (Nationalrat) and the Council of States (Ständerat). The National Council is the 
bigger chamber. It consists of 200 members who are elected by proportional representation. 
The Council of States is composed of 46 members and is elected by a majority vote system. 
Both chambers have equal political weight and their separate commissions for individual 
policy fields. In cases of disagreement between the two chambers (as in 
xenotransplantation) a procedure for settling differences (Differenzbereinigungsverfahren) is 
initiated so as to find a compromise. If this cannot be accomplished the bill fails. 
In comparison to the government the resources of the Parliament, e.g., regarding support 
staff, are limited. The government therefore (and because of its daily routine of implementing 
laws and administration) has an advantage in comparison to Parliament in terms of 
knowledge and resources available and plays a very active role in legislation. However, 
Parliament also has a decisive part to play and the government‘s bills do not always pass the 
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two chambers without substantial amendments. The parliamentary commissions deliberate 
bills in depth and in the case of xenotransplantation the FOPH failed with its proposal 
(Interview 4: 151-158). 
In the case of xenotransplantation the FOPH used formal and informal consultation 
processes order to develop its policies. These processes resulted in a message to 
Parliament. The FOPH also used the PubliForum as an information source to support its 
position, which is partly critical of experts from transplantation medicine. 
Important documents of this policy process include draft bills, statements made during the 
consultation, the report on the consultation procedure and the message to Parliament. 
5.1.2.1 Political Practices in Parliament 
In the case of xenotransplantation Members of Parliament used the instrument of 
interpellation, in which they address government and ask questions. This is a parliamentary 
instrument of the first choice (Interview 3). Another instrument is the parliamentary initiative 
in which Members of Parliament address the responsible parliamentary commission, which 
deliberates and decides on the proposal. Finally there are motions, either addressed at the 
government or the plenary, asking for certain steps, to be taken or for amendments of 
proposed laws to be made for example. An important mechanism is the procedure followed 
to settle differences between the two Chambers. All of these practices were applied in the 
regulation of xenotransplantation (see also Appendix). 
5.1.2.2 How to get information 
Policy makers used various sources In order to get information: 
 The FOPH used reports on international regulatory initiatives and expert opinions. 
Moreover it was involved in discussions with the Council of Europe, the OECD and 
the WHO. 
 Critical members of Parliament used materials from NGOs (such as Basel Appeal) 
and press reviews compiled by the parliamentary staff. 
 The responsible parliamentary committee organized a hearing with experts for and 
against xenotransplantation. 
 In the plenary debate speaker mention informal negotiations between Members of 
Parliament and interest groups‘ representatives. But there are no documents 
available which would corroborate this claim. 
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5.1.3 Features of the Political System 
Federalism is an important element of the Swiss political system. The 26 cantons have their 
own constitution and have tax authority on most taxes. The Federation has competence in 
questions of technological development. Policy, education and churches are regulated by the 
cantons. 
The Swiss political system is characterized by a division and an interconnection of power 
between the executive and legislative but also by the autonomy of cantons, interest groups, 
parties and single institutions such as the government. All of these are proportionally 
represented in decision-making processes and have veto power. Switzerland is therefore the 
ideal concordance democracy. Advantages of this system include the integration of interest 
groups, the protection of minorities and that solutions find broad acceptance. Disadvantages 
include lengthy decision-making processes, a strong notion of elite cooperation and a lack of 
transparency to outsiders of the system. 
Election results do not determine the composition of government because of the magic 
formula. Members of Parliament must not be instructed and are only responsible to their 
conscience. Parties therefore play a less important role than in other democracies. 
Another of the main features of the Swiss political system is its orientation towards 
consensus. The constitution lays down the principle of collegiality in government, i.e. the 
Federal Council has to find a common policy. Single Federal Councillors have an absolute 
veto but taking a vote is always a possibility. This orientation towards consensus is also 
expressed in the magic formula. The already described consultation procedure in law making 
is another expression of this consensus orientation. Swiss decision-making processes 
therefore take a long time but the resulting compromises are often widely accepted by 
Parliament, parties in Parliament, interest groups and the electorate. 
During an interview a politician considered her work in the regulation of xenotransplantation 
as rather successful because she was able to create a certain public audience for the topic. 
Because the final outcome of the political process was a compromise; there was, on the one 
hand, not a complete ban of xenotransplantation and on the other hand, obligatory 
governmental authorization creating oversight on xenotransplantation in clinical trials. The 
solution to allow xenotransplantation after prior authorization was a kind of middle ground. 
This notion of finding a compromise is, from her perspective, rather typical for Switzerland. 
(Interview 522-534). 
Another characteristic of the Swiss political system identified by an interview partner is its 
general pragmatism, in the sense of concentrating on given circumstances. In her opinion 
basic questions about society‘s ideas in general are increasingly rarely debated since 1968. 
Instead, there is a dominant notion of pragmatism in Swiss society. This attitude was 
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expressed in the context of xenotransplantation since animal welfare and the question of 
viruses was taken seriously but pragmatically integrated into the xenotransplantation 
regulation by stating that organs have to be tested for viruses before transplantation 
(Transplantation Law Article 47). The fundamental question, however, whether 
xenotransplantation as a technology should be further pursued at all, was hardly debated in 
this pragmatic approach (Interview 3: 138-177). 
Although TA as a concept and process in the way xenotransplantation was dealt with in 
policy making was new, the problem nevertheless was framed by this general pattern of 
pragmatism where problems were identified, addressed and finally ticked off. The notion of 
pragmatism implies a technical solutions, i.e., that organs should not be afflicted with 
viruses, animals should be kept according to regulations and that the question of 
xenotransplantation should be settled by experts, i.e., scientists and physicians (Interview 
3:410-425). 
Another way to describe this typical pragmatism is to describe the Swiss, as opposed to the 
technology affine US-Americans and the technology skeptical Europeans, as very realistic 
and belonging to the middle ground. To substantiate this claim one interviewee pointed out 
the public referenda in which the Swiss would vote on factual issues every two months. In 
these the Swiss would be very realistic and reasonable (Interview 8: 192-209). This kind of 
pragmatism is also expressed in the repeated insistence of TA-researchers during interviews 
that it is justified that firms should yield profit from xenotransplantation. 
5.2 Social Practices in the Field of Citizen Participation 
The social field of citizen participation is particularly rich in Switzerland. Elites play a strong 
role in the political system but the electorate can play an active role by means of initiatives 
and referenda. Since the threat of a referendum that might overturn a law always exists, "the 
entire Swiss political system is intended to avoid a referendum" (Interview 9: 300). 
However, in this area interest groups are also important. They raise issues for direct 
democracy and try to create majorities in referenda and initiatives. Thus the people are a 
control factor in most important questions and a significant veto player that can force the 
political elite to react by threatening with loss of power and reputation. Overall, there are 
general elections, referenda, initiatives and consultation procedures that involve citizens. 
In the case of xenotransplantation citizen participation consisted of a petition signed by 6,500 
citizens demanding a moratorium. There was also a formal consultation procedure for the 
law on transplantation and the informal consultation procedure on the Federal Decree on 
Blood and Blood Products, which NGOs used as an opportunity to voice their critique. 
Moreover there was a referendum on whether or not to take the regulation of transplantation 
to the federal level. No evidence of any demonstrations was found. 
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6 Conclusions 
6.1 Xenotransplantation Policy 
Swiss xenotransplantation policy is cautious but in principle permissive. Clinical trials are 
allowed after prior authorization and when meeting strict requirements. This policy was 
actually decided on when in 1999 a majority in parliament turned a governmental proposal 
on the prohibition of xenotransplantation with exceptions into permission with certain 
requirements and prior authorization. This turn of policy was justified with the argument of 
not wanting to isolate and harm Swiss businesses and the Swiss research location. This 
approach, despite wide criticism from NGOs, was continued in 2001 in the new 
transplantation law and was also supported by the majority of the PubliForum. 
The regulation of xenotransplantation is connected to two strands of legislation, which reach 
back into the early 1990s. 
First, it is linked to the development of a transplantation law. Until a federal law was passed 
in 2004, which came into effect in 2007, transplantation was under legislation of the 26 
cantons and thus regulated rather diversely. In the 1990s the Federal Assembly asked for 
federal competence in this area. For this a constitutional amendment was necessary which 
the electorate had to approve by referendum. The regulation of xenotransplantation fell into 
this lengthy process of passing a new transplantation law. It was only one of several issues 
that were raised and was primarily discussed in the context of concerns about risk and public 
health. It was also discussed in relation to the Swiss research and business location. Issues 
of animal rights and ethics were less central. 
Secondly, xenotransplantation was framed in the context of regulating blood, blood products 
and transplants regarding a risk of infection. When the issue of xenotransplantation entered 
the political agenda in 1996, basically on the initiative of the biotechnology critical NGO 
Basel Appeal and a Member of Parliament who was connected to this group, government 
initially planned to regulate the topic within the then pending comprehensive transplantation 
law. The government suggested regulating the topic by amending the Federal Decree on the 
Control of Blood, Blood Products and Transplants, which regulated protection against 
infection. It did so after a parliamentary initiative by a biotechnology critical Member of 
Parliament and a subsequent motion of the responsible parliamentary commission to 
regulate xenotransplantation quickly and to make it subject to prior authorization. It was 
through this process that the basic elements of a xenotransplantation regulation were 
debated and finally decided on. After a heated debate in both chambers, which resulted in 
diverging decisions, the National Council finally agreed with the Council of States. They 
decided against the governmental proposal of a ban on xenotransplantation with exceptions 
and against motions by Social Democrats and Greens for a ban or moratorium respectively. 
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They did so with the votes of both conservatives and liberals and, because of arguments for 
securing the Swiss research and business location, decided for a permissive regulation. This 
regulation included prior authorization after certain requirements regarding safety and liability 
have been met. 
Important actors in this legislative process were the responsible FOPH, both chambers of the 
Federal Assembly, the National Council and the Council of States, and the electorate. The 
responsible authority, the FOPH drafted the regulation but both chambers of Parliament 
were also important because they initiated the regulatory process by making interpellations 
to government, addressing parliamentary initiatives at the responsible parliamentary 
commissions, making parliamentary motions to government and finally by changing the 
governmental bill significantly in regards to the ban of xenotransplantation. Other important 
actors were biotechnology critical NGOs, namely Basel Appeal, various interest 
associations, the pharmaceutical industry, namely Novartis and experts from science, 
medicine and ethics. 
Civil societies‘ activities in regards to xenotransplantation contributed and were connected to 
the legislative process. The NGO Basel Appeal was very active in the field of 
xenotransplantation and collected signatures for a moratorium on xenotransplantation in 
1996. This NGO also had connections to Parliament since one of the members of its board 
was also member of the Federal Assembly. This person initiated an interpellation and a 
motion for a moratorium on xenotransplantation in 1996. 
Important procedures within the law making process were parliamentary initiatives, 
interpellations to government, motions by Parliament, and procedures of parliamentary 
negotiations (Differenzbereinigung). Moreover, at the level of drafting a law, formal and 
informal consultation processes were important in which cantons, ministries, representatives 
of interest groups, civil society organizations and, in principle, each Swiss citizen can voice 
his/her opinion about a bill. Another important practice is the sending of a message 
(Botschaft) to Parliament in which the executive proposes a draft bill to Parliament. Finally 
internal rules of procedure of Parliament are of importance. 
Throughout the policy making process a number of (mostly written) artifacts w produced. 
However, they are mostly available to the researcher in their final and official form. These 
documents include reports on the consultation process and extensive messages to 
Parliament, both written by civil servants, as well as interpellations, parliamentary initiatives 
and motions, formulated by members of the legislative and their staff. These documents are 
both the result of and means of policy-making. In addition there are verbatim records of 
parliamentary debate. A different kind of artifact is provided by press debates. Press 
releases are another kind of document and these are not directly addressed to the policy-
making process and its actors but to the general public. Media reports, authored by 
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journalists, are yet another kind of kind of document. They often provide background 
information, which is not available in official sources. 
6.2 TA and PTA 
In Switzerland two expert TA studies on xenotransplantation were carried out. They were 
commissioned so as to get an overview of the field and its implications for Switzerland. TA 
Swiss, which by then was connected to the Federal Assembly, took the initiative to organize 
these TA exercises. It did so because it perceived xenotransplantation as an up and coming 
biomedical development of which the social and ethical impact required closer investigation. 
After an open call for tender, TA Swiss commissioned the FhG-ISI to carry out an expert TA 
study on solid organ xenotransplantation which, by asking stakeholders for their written 
opinions, also included elements of invited participation. By the means of an advisory group 
staffed by experts, Members of Parliament and representatives of the FOPH TA Swiss 
already tried to connect the study with the social and political context of xenotransplantation. 
The project results (Hüsing et al. 1998) were presented to policy makers and the public. 
TA Swiss thereafter organized a PTA, called PubliForum, to get a qualitative picture about 
what lay citizens thought about the regulation of transplantation medicine more generally and 
about xenotransplantation in particular and what policy they recommended as appropriate. 
For this exercise TA Swiss took into account the results of the aforementioned TA study, 
lessons learned from their first PubliForum and international research on PTA. They decided 
to broaden the topic of their planned PubliForum from xenotransplantation to transplantation 
because of the then discussed transplantation law. By involving the responsible FOPH and 
the Swiss National Science Foundation as co-financers they also connected the PubliForum 
to the policy process and broadened its financial basis. The FOPH was interested in the 
PublForum because it wanted to gain more information on what the public thought about 
transplantation. 
Based on the Danish consensus conference model, the PubliForum involved 28 citizens who 
were selected to represent Swiss population. The citizens had significant influence on 
framing the issue by raising the questions they wanted to discuss, and inviting the experts 
they wanted to hear. They were able to discuss the issues with experts and were considered 
knowledgeable. Supported by TA Swiss and the moderator, they formulated a report, which 
they presented to members of Parliament, the responsible ministry and a main Swiss 
research funding organisation. Thus the outcome of the PubliForum was well disseminated 
into and connected to established policy-making mechanisms. However, it seems the results 
of the PubiForum were not disseminated as widely to the general public. 
Swiss xenotransplantation policy cannot be directly linked to the outcome of the PTA 
because the basic decision on this policy was already made prior to the PubliForum. 
Moreover, the majority of the PubliForum supported government policy. Thus, the 
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PubliForum had a legitimizing impact on policy making since the recommendation 
corresponded with and supported government policy. It is hard to predict what would have 
happened if the PubliForum had not agreed with government policy. In addition, there were 
also other important and indirect impacts of the PubliForum on the policy field. 
Expert TA and PubliForum were well received in the political system. The TA study was 
discussed in Parliament and its quality was recognized in the parliamentary debate. It was 
extensively referred to in documents of the responsible ministry and in the message to 
Parliament. The opinion of the PubliForum with regards to xenotransplantation was also 
shared by the FOPH and the Federal Assembly. The high quality of TA and PTA established 
the legitimacy of the processes. Their quality was neither questioned in interviews nor official 
documents. In general policy makers had good experiences with the TA and PTA. A press 
release of the FOPH referred to the PubliForum and its outcome and claimed that these had 
an impact. The PubliForum was also well received within the executive and by researchers. 
In summary, TA Swiss carried out a high quality TA that was followed by a state of the art 
PTA. 
The PubliForum on transplantation, which also included the question of xenotransplantation, 
was not the first of TA-Swiss‘s PTAs. It became a standard procedure, which is not used in 
all cases of TA however. Additional instruments are shorter versions such as PubliTalk and 
PubliFocus. Other PubliForums on other topics followed but these were more infrequent. 
However, interview partners also expressed their impression that PTA was kind of en vogue 
in those days and that interest in them recently dwindled to a certain extent (Interview 4: 
327-344). 
6.3 PTA in the context of Swiss politics 
The Swiss political system is characterized by subtle balances between four language 
groups, cantonal and federal competencies and different political parties. In addition there 
are tensions between representative democracy and direct democracy as well as a strong 
emphasis on civil society, eulogizing independent citizens.
21
 In an environment of latent 
tensions and a delicate balance between these positions there is a strong notion of 
compromise ensuring that a shared community is sustained. This is expressed, e.g., in 
mechanisms such as the magical formula, the principle of collegiality and the consultation 
procedure in law making. Compromises are facilitated by a political discourse with a 
particular notion of sobriety, pragmatism and orientation on factual questions as well as, at 
least in the context of xenotransplantation, avoidance of radical stances and questions. 
Thus, to a certain extent PTA fits well with the main characteristics of the Swiss political 
system and serves several of its basic needs; i.e., a need for factual and sober discussion by 
                                                     
21
 Swiss direct democracy developed from a 19
th
 century grass roots movement which distrusted representative 
democracy and wanted to limit the power of parliament and control the most important decisions (Linder 1999a: 
463). 
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ordinary, independent citizens in order to inform policy makers, who in a fragile and 
polycentric political system are always threatened by a popular veto power. As one 
researcher expressed his opinion, PTA fits direct democracy since it provides new 
information, discusses things and does not remain on a polemic level of newspapers 
(Interview 8: 375-389). In this way a PTA such as the PubliForum can be interpreted as 
another mechanism within Swiss concordance democracy (Interview 9: 348-351). 
The interviews showed that PTA such as a PubliForum is particularly well suited to 
complement existing possibilities of the Swiss electorate to participate in legislation and 
political decision-making: A consultation is only carried out in the context of legislation. 
Moreover, in reality the consultation mechanism is geared towards involving organized 
political actors. The right to initiative is a way for citizens to become active but is always 
geared towards constitutional changes. A referendum is always post-festum, when a law has 
been passed and the electorate can vote on it. 
In contrast, the PubliForum provides a means for the executive to actively approach a group 
of citizens, composed as much as possible of representatives of the population, and to invite 
them to voice their opinion on a topic. Being open to normal citizens it is a much more 
informal and low-threshold
22
 approach than a consultation because ordinary citizens are 
often not conscious of their right to voice their opinion in a consultation. This consultative 
instrument is mostly used by established political organizations and authorities. In contrast 
the PubliForum is much more open and the quality of the output is different because it is less 
controlled by politically active and mobile institutions or organizations and is much closer to 
the "real citizen" (Interview 4: 255-281). 
On the other hand, it seems that the PTA is less directed at the general public than at policy 
makers. It was more noticed by policy makers than by media and was relatively well 
integrated into the political decision-making processes. 
It should also be kept in mind that the embedding of PTA in the Swiss system draws a 
perhaps too idealistic picture. Neither TA nor PTA is uncontested in the Swiss political 
system (Interview 4: 327-344). TA-Swiss had to face criticism from political parties 
advocating a lean state and glorifying the role of individual citizens and the electorate in 
referenda. One interviewee recalled that TA Swiss had to justify itself as an organization at 
the time when they started the TA on xenotransplantation and were still young as a TA-
institution (Interview 2 70-72). However, it seems that TA Swiss has gained in reputation by 
now. Though politicians from the left and the right were skeptical in the beginning, the 
acceptance of PTA by politics has increased since politicians became accustomed to the 
procedure and the fact that PTA delivered qualitatively good reports. Although there are still 
                                                     
22
 In the sense of providing in principle easy access for ordinary citizens. 
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some politicians who remain skeptical, TA-Swiss has a good image in general and the value 
of the PTA process is accepted (Interview 1: 402-407). 
The dividing line with regards to TA and PTA seems to follow the distinction between left and 
right. One interview partner emphasized a different aspect regarding the question of PTA 
acceptance. In his view parties from the political right perceive PTA as unnecessary given 
that there is discussion in Parliament and the option for a referendum would always exist. 
One TA researcher assessed the situation of PTA in Switzerland as follows: Some politicians 
doubt the necessity of a PubliForum because they argue there always the opportunity for a 
referendum and they would know what people think anyway when they visit markets and 
shake people‘s hands. Since they already represent the people, a PubliForum is not 
necessary would only be expensive. In general there is therefore no big euphoria for these 
instruments but some politicians remain enthusiastic (Interview 9: 378-387). 
The political left on the other hand is more positive about PTA. In general acceptance of PTA 
is also dependent on the particular topic and, if connected to an ongoing regulatory process, 
PTA might help suggestions and concerns to be accepted at an early time (Interview 5: 46-
464). 
Parliament, according to an interview partner, leaves great leeway to experts when topics of 
science and research are raised. The idea that every man and woman could discuss societal 
and psychological consequences in cases such as xenotransplantation did not meet with 
much conviction. It was often said that one would see the dangers and that they should be 
clarified by experts (Interview 3: 200-205). However, this politician was also skeptical about 
the PubliForum; she thought that the format might be too much open to the threat of 
manipulation by the way in which experts are selected. The PubliForum might also ask too 
much from citizens without prior information (Interview 3: 443-463). 
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7 Annexes 
7.1 Outline of the Political System 
The following short and rough outline of the Swiss political system shall help to embed the 
case study within the context of the Swiss political system and is mainly derived from Linder 
(1999a, 1999b, 2009) and Lüthi 1999. 
7.1.1 Cabinets 
Were the governments in the last two decades single party (UK) or coalition governments 
(NL, Ger), minority or majority governments; were they dominated by a certain party? 
Swiss Government, the Federal Council (Bundesrat) is composed of seven members 
(Councilors) who are elected individually by the United Federal Assembly (National Council, 
Nationalrat and Council of States, Ständerat) for a four years term. There is no possibility of 
deselect or a vote of no-confidence of a single member or of the entire Federal Council. 
The composition of the Federal Council acknowledges the country‘s multi-ethnicity as well as 
the strength of political parties in long term perspective. German speaking Swiss have 4 
seats, French speaking 2 and the Italian speaking 1 seat. Since 1959 the Federal Councils is 
composed of representatives of the four major parties. Until 2003 the so called magic 
formula (Zauberformel) stipulated that the Free Democratic Party (FDP) had 2 members, the 
Christian Democratic People‘s Party (CVP) 2 members, the Social Democratic Party (SP) 2 
members and the Swiss People‘s Party (SVP) 1 member. The rule of proportional 
representation of language groups and parties is a major characteristic of Swiss 
concordance democracy and is not laid down in the constitution but is a tradition followed by 
political actors voluntarily (Linder 1999a: 459-460). Since the 2003 elections which made the 
conservative populist SVP the strongest party, the concordance system is under pressure 
but nevertheless – with slight modifications - is still in place after some turbulences (Linder 
209: 571, 573, 597). 
The Federal Council is a collegial organ and its decisions are made with single majority. In 
reality the position of Swiss government is close to a presidential system. 
7.1.2 Legislature 
Does it feature two chambers (Ger, I) or one (F)? Who are they representing and which one 
is more powerful? Where do the Members of Parliament get their information from (own staff, 
scientific service of parliament, federal ministries, interest groups/social partners)? 
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Parliament is the highest political institution. However, its competences are delimited by the 
strong role of government, the strong elements of direct democracy and the involvement of 
interest organizations (see below). Swiss Parliament is a working parliament, however in 
comparison to the executive with a much smaller infrastructure. It has the right to initiate and 
pass laws and budget, financial planning as well as to supervise government and 
administration. It elects the Federal Council and the Federal Court and the army chief in war. 
Its two chambers, the National Council (200 seats) and the Council of States (46 seats) are 
equally important. In order to pass, a bill has to find a majority in both chambers. In cases of 
disagreement between the two chambers - which deal both with each bill separately and 
completely - a procedure is launched to settle the difference. If these negotiations do not 
succeed, the law fails (Linder 1999a: 461ff.). Swiss parliamentarians are working in a the so 
called ―Milizsystem‖, i.e. they have a civilian profession and their political mandate is 
considered an additional occupation. 
7.1.3 Executive-Legislative Relationship 
Is it a relatively more consensual (B, CH) or rather antagonistic (US) relationship? Is the 
legislative more independent with a number of control rights (US) or less so, with most laws 
being steered through Parliament by the executive (A)? 
The Swiss parliament has a strong formal role in legislation. It can refuse a governmental bill 
without discussing it in content and can make detailed changes. By parliamentary initiatives 
it can also make laws without the involvement of Government and administration. It has a 
question right (―Anfrage‖) and the right to request from a comment to a question 
(―Interpellation‖). Moreover, there are the instruments of ―Postulat‖ in which Parliament asks 
Government to examine whether it would be possible to draft a law and the ―Motion‖ which 
orders a law by Government. Because of the strong role of the Federal Council in the Swiss 
political system the political majority in Parliament is less concerned with retaining the power 
of Government and can play an independent and strong role as well (Linder 1999a: 462). 
7.1.4 Bureaucracy 
What is the role of the bureaucracy in all of this? is it dominant (J, classical Westminster 
model) or dominated (US), is it large (NL) or small (S), does it operate at arm‟s length from 
government (UK, S) for is it more directly attached (Ger, I)? 
Switzerland features a relatively small bureaucracy (Linder 1999a: 476). The public 
administration plays an important role in lawmaking since expert knowledge and experience 
with implementation of laws accumulate in the civil service (Linder 1999a: 469). In most 
cases bills are prepared by the Federal Council and administration (94.2% of all laws 
between 1991-1995, Lüthi 1999: 139). The influence of the parliament on legislation is 
perceived differently in the literature. While some authors only see a marginal role of 
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parliament in legislature and emphasize the importance of the Federal Council as well as 
public administration other authors call attention to the fact that government drafts are often 
modified during parliamentary negotiations (Lüthi 1999: 142). Lüthi therefore concludes 
optimistically: ―Das Parlament greift also in den Rechtsetzungsprozess ein, allerdings 
selektiv‖ (―Parliament engages in the legislative process, though selectively‖, ibid.). 
7.1.5 Judicial Review 
Are the courts important for political decisions (US, Ger) or relatively less so (A)? 
The Federal Court rules about conflicts regarding the implementation of federal law. It 
examines the constitutionality of cantonal and communal regulations and guarantees the 
basic rights. 
7.1.6 Party System 
How many parties have been represented in Parliament, is any of these dominant? 
Parties lack a strong role in the Swiss political system. They are neither mentioned in the 
constitution, nor are they subject to a specific law or financed by the state. They are 
organized on cantonal level. Large parties are included in Government (FdP, CVP, SPS, 
SVP), whereas smaller parties remain in opposition (Linder 1999a: 471ff.). Within 
concordance democracy which does not know the regular change between government and 
opposition competition between parties is restricted to increasing the proportional 
representation in Government. During referenda, however, political parties can occasionally 
take the role of an opposition party (Linder 1999b: 25). Since the 1990s the SVP acts as a 
opposition party against the other government parties as regards European integration and 
in this way accomplished to become the strongest political party (Linder 2009: 587). 
7.1.7 Interest group system 
Is the country more corporatist with powerful trade unions, collective bargaining of wages 
and cooperation between the state, trade unions and business interests (A, NL, S) or is it 
rather pluralist with a lot of interest groups and little coordination (US, UK)? Are business 
interests privileged and in which way? 
The political system is also characterized by a strong role of interest organizations which 
contribute to the policy making process. Swiss corporatism is not only focused on the conflict 
between capital and labor and is characterized by the fact that employees organizations are 
less well represented than in comparable countries such as Austria (Linder 2009: 590). The 
interest group systems has two layers, on the first level there are several occupational and 
branch organisations, on the second level umbrella organization, e.g. Swiss Business 
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Federation, Swiss Farmers Union, Swiss Federations of Trade Unions. They integrate the 
interest of their member and try to influence regulation. Interest ogranisations play a strong 
role, particularly in economic policy. Recently Swiss corportatism faces difficulties due to less 
cohesion within the interest organizations but also because of globalization. Beside these 
organizations there are numerous NGOs in the area of social, consumer and environmental 
policy. 
7.1.8 Direct Democracy 
What instruments of direct democracy are provided for by the constitution (e.g. plebiscite, 
popular initiative by a certain number of signatures, mandatory referendum in the case of 
constitutional changes, petitions signed by a certain number of MPs/voters to be processed 
by Parliament) and have they been important until now? 
Direct democracy plays a central role in the Swiss political system. The instruments of direct 
democracy developed from a distrust in the representative system (Linder 1999b: 463) and 
include 
1. obligatory constitutional referendum 
2. facultative referendum on laws  
3. people‘s initiative. 
Obligatory constitutional referendum is necessary for constitutional amendments and treaties 
dealing with the accession to organization for collective security and supranational 
communities. 
The facultative referendum entails that laws and some international treaties have a 
referendum clause that means that if 50.000 voters are calling for a referendum within three 
months after signature the decision is made subject to a plebiscite. 
A minimum of 100.000 citizens can call for constitutional amendments (abolishment, change 
or creation of a new paragraph). If such a people‘s initiative succeeds in getting enough 
support the Federal Council and Parliament have to deal with the subject and suggest to the 
electorate a - in most cases negative - recommendation. Parliament can also make a 
counterproposal. The people‘s initiative is an instrument that brings many innovations in the 
political system. Though only 10% of them are successful, their issues are sometimes taken 
up by Parliament and are included in subsequent legislation. 
Annually the electorate has to vote on approximately six constitutional changes and two to 
four referenda on laws (Linder 1999a: 462 ff.). 
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Because of the check and balance between Federal Council, Parliament and electorate, in 
other words between representative democratic and direct democratic elements, which 
should enable co-determination of the voters not in all, but the most important matters 
(Linder 1999a:463), the system is also called ―half-direct-democracy‖ (ibid.). 
7.1.9 Political culture 
How strong is civil society, is there a tradition of participation in politics, how open is 
decision-making? 
Switzerland is the model of consensus democracy which involves federal structure, 
concordance and power sharing. Power sharing is based on federalism, subsidiarity and 
voluntary proportional representation in assigning different political offices with regards to 
language, party affiliation and gender (Linder 1999a: 467 ff.). The concordance system can 
be explained against the background of direct democracy, which poses a continuous threat 
to decisions taken in the representative system. Involving the main political parties 
considerably reduces the risks for plebiscitary defeat. Thus the voters‘ rights in the Swiss 
political system pose a strong coercion towards concordance. However, it has to be kept in 
mind that the concordance system developed slowly over decades since the mid 19
th
 century 
from a political struggle with the then dominant Liberals in which different political 
movements struggled for political power and were subsequently included in government (i.e. 
Catholic-Conservatives in 1891; Farmers-, Trading and Citizens-Party after World War I and 
finally the Social Democrats only in 1959, Linder 1999a: 468, 1999b: 14ff). 
7.1.10 Science-Society Relations 
What is the role of scientific experts and of expertise in society and in policy-making? 
Experts are involved in commissions in the pre-parliamentary process of legislature (Linder 
1999a: 476 ff.). 
7.1.11 Constitutional Division of Territorial Power 
Is the central state more powerful (F) or are the regions important (B, CH, Ger), and which 
issues are decided by the regions and are there veto points arising from federalism? 
Switzerland is a state with strong federalist elements. Federalism was important for a 
peaceful coexistence of different ethnicities and religious groups. The Federation and the 26 
cantons have their own constitutions and the about 3.000 communities enjoy large 
autonomy. Federation, cantons and communities levy income and property taxes. The 
implementation of the concept of subsidiarity turns Switzerland into one of the most 
decentralized countries (Linder 1999a: 457). 
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7.1.12 Electoral System 
Is it relatively more disproportional (US, UK) or less so (Ger, I) and how strong are minority 
rights (could green parties come into existence). 
The seats of the National Council are distributed by proportional representation. The Council 
of States is elected according to different cantonal rules, mostly majority vote system. 
7.2 Policy Field 
7.2.1 Cabinets 
Did they have a role in the policy field for the problems handled by e.g. the bureaucracy? 
During the 1970s and 1980s federal government refused to create a specific law on 
biotechnology. This ended in 1987 with the people‘s initiative for ―Restricting the abuse of 
reproductive medicine and gene technology in humans‖, which was accepted as revised 
version with 74% in favor. In the 1990s the discussion about biotechnology got more 
controversial and in 1992 another people‘s initiative was launched (―Gene-Protection-
Initiative‖) and received necessary support in 1993. Government by this pressure was forced 
to leave its laissez-fair approach and accepted to develop a regulation. 
7.2.2 Legislature 
Did it have a role (if yes, which chamber) in the policy field for the problems tackled by e.g. 
the bureaucracy? 
In 1997 the biotechnology critical peoples‘ initiative (―Gene-Protection-Initiative‖) had realistic 
chances to succeed. As a reaction the ―pro-gene lobbyist in parliament‖ (Bonfadelli et al. 
2002: 114) drafted a law to regulate the issues which were not covered by Swiss legislation 
so far and counter the critical initiative. The Federal Government produced in a record time a 
second draft of this law, the ―Gene Lex Package‖, to show that government was willing ―to 
seriously take into account the concerns of the Swiss population, and to develop strict 
regulations for gene technology‖ (Bonfadelli et al. 2002: 115). Government opposed the 
―Gene-Protection-Initiative‖. After the rejection of the Gene-Protection-Initiative in June 1998 
by 66.6% of the voters (at a turnout of 40.6 %) – after a fierce and controversial campaign - 
the ―gene law‖ was drafted and debated in 2000 (ibid.) and finally adopted in 2003. 
7.2.3 Executive-Legislative relationship 
Is there a history of adversarial relations between executive and legislative in the policy field 
(e.g. over leadership on issues, media attention? 
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There seems to be no history of adversarial relations between executive and legislative in 
this policy field. 
7.2.4 Judicial Review 
Are the courts important for the policy field? 
The courts dealt with biotechnology repeatedly, e.g. in the case of ART the Federal Court 
ruled against restrictive cantons and contributed in this way to a law which did not totally ban 
ART (Rothmayr 2006: 607). 
7.2.5 Party system 
Were some parties represented in Parliament interested in the policy field (e.g. the Greens)? 
Conservative parties opposed the Gene-Technology-initiative, while the political left, part of 
the Social Democrats and the Green party were in favor. 
7.2.6 Interest Group System 
Were some interest groups involved in the policy field (e.g. pharmaceutical industry, 
Chamber of Commerce, professional associations)? 
Opponents of the Gene Protection Initiative were university researchers and the 
pharmaceutical industry, who considered this initiative as a threat to their existence 
(Bonfadelli 202: 115). Switzerland has a ―powerful pharmaceutical industry, which on other 
occasions had successfully campaigned in favor of red biotechnology (i.e. medical 
applications)‖ (Rothmayr 2006: 615). There are also a number of NGOs which are critical of 
biotechnology, e.g. Basler Appell. 
7.2.7 Political Culture 
Has civil society been involved in the regulation of XTP or in similar problems, how open is 
decision-making in this policy field? 
Because of its large involvement in pharmaceutical and agricultural industries by 
multinational companies and many start-up firms biotechnology policy is high on the political 
agenda in Switzerland. Several people‘s initiatives dealt with the topic of biotechnology 
(Beobachter-Initiative in 1998, Gene-Protection-Initiative 1998, Bonfadelli et al 2002: 113, 
Rothmayr 2006: 611 ff.). 
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7.2.8 Science-Society Relations 
What is the role of scientific experts in this policy field? 
Scientist tried to promote their cause successfully in the ―Gene-Protection-Initiative‖ 
(Bonfadelli et al. 2002) and less successfully in the ―Beobachter Initiative‖ which led to a 
restrictive regulation of assisted reproductive technologies (ART, Rothmayr 2006: 611). They 
even made a protest march against the ―Gene-protection-Initiative‖ in 1998 (Bonfadelli et al. 
2002: 115). 
7.2.9 Direct Democracy 
Were there attempts to use instruments of direct democracy in the policy field (e.g. petitions 
on GMO, BSE)? 
Policy development was heavily influenced by subsequent peoples‘ initiatives on the issue of 
biotechnology (see above). 
7.2.10 Constitutional Division of territorial power 
Were some regions more active than others in the policy field (e.g. in the form of funding 
programmes, regulations? 
In the case of ART (Rothmayr 2006: 598, 607) as well as transplantation medicine 
competencies were first with cantons and were later transferred to the Federation. 
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Institute für Systemtechnik und Innovationsforschung) 
FOPH   Federal Office for Public Health (Bundesamt für Gesundheit) 
PTA  Participative Technology Assessment 
SNF   Swiss National Fund 
SPS  Social Democratic Party 
SVP  Swiss People‘s Party 
TA  Technology Assessment 
TP  Transplantation 
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